Report for Combined Biotech 13F Filings for quarter ending on 2025-09-30 (Compiled by Finradar.ai) (Adar1, Avoro, Baker Brothers, BVF, Casdin, Cormorant, Deep Track, EcoR1, Logos, Opaleye, Orbimed, Perceptive, RA Capital, Tang)
Top 40 Stock Holdings by Value
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|
| 0 | ASND | 2025-09-30 | Ascendis Pharma A/S | 59,372,631.00 | 2015-01-28 | 3321766586 | 16708247 | 5 | adar1-avoro-perceptive-racapital-orbimed |
| 1 | INCY | 2025-09-30 | Incyte Corporation | 161,370,279.00 | 1993-11-04 | 2615851059 | 30843663 | 2 | baker-casdin |
| 2 | MDGL | 2025-09-30 | Madrigal Pharmaceuticals, Inc. | 11,356,312.00 | 2007-02-06 | 1859681002 | 4054596 | 4 | adar1-avoro-baker-ecor1 |
| 3 | RYTM | 2025-09-30 | Rhythm Pharmaceuticals, Inc. | 46,955,630.00 | 2017-10-09 | 1521707219 | 431317234 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye |
| 4 | INSM | 2025-09-30 | Insmed Incorporated | 166,410,802.00 | 2000-06-01 | 1159147003 | 8049073 | 5 | baker-cormorant-perceptive-orbimed-tang |
| 5 | KYMR | 2025-09-30 | Kymera Therapeutics, Inc. | 42,816,370.00 | 2020-08-21 | 1071094721 | 18923935 | 5 | avoro-baker-bvf-logos-perceptive |
| 6 | RNA | 2025-09-30 | Avidity Biosciences, Inc. | 92,698,110.00 | 2020-06-12 | 960656326 | 22048573 | 9 | adar1-avoro-baker-casdin-cormorant-ecor1-logos-racapital-orbimed |
| 7 | ACAD | 2025-09-30 | ACADIA Pharmaceuticals Inc. | 114,380,229.00 | 2004-05-27 | 949667879 | 44501775 | 3 | baker-deeptrack-tang |
| 8 | UTHR | 2025-09-30 | United Therapeutics Corporation | 41,324,592.00 | 1999-06-17 | 900598066 | 2148322 | 3 | adar1-avoro-orbimed |
| 9 | ARGX | 2025-09-30 | argenx SE | 60,989,637.00 | 2017-05-18 | 885116254 | 1200060 | 3 | avoro-baker-orbimed |
| 10 | RVMD | 2025-09-30 | Revolution Medicines, Inc. | 168,212,518.00 | 2020-02-13 | 848386711 | 18166739 | 7 | adar1-baker-bvf-casdin-logos-opaleye-tang |
| 11 | SMMT | 2025-09-30 | Summit Therapeutics Inc. | 111,183,085.00 | 2015-03-05 | 710206983 | 34375943 | 3 | adar1-baker-tang |
| 12 | EWTX | 2025-09-30 | Edgewise Therapeutics, Inc. | 54,187,991.00 | 2021-03-26 | 681727622 | 42030063 | 8 | adar1-baker-cormorant-perceptive-racapital-orbimed-opaleye-tang |
| 13 | CELC | 2025-09-30 | Celcuity Inc. | 20,768,907.00 | 2017-09-20 | 630568869 | 12764552 | 5 | baker-bvf-perceptive-orbimed-tang |
| 14 | PCVX | 2025-09-30 | Vaxcyte, Inc. | 119,134,116.00 | 2020-06-12 | 609456239 | 16919940 | 7 | adar1-baker-cormorant-deeptrack-logos-racapital-tang |
| 15 | APLS | 2025-09-30 | Apellis Pharmaceuticals, Inc. | 84,226,131.00 | 2017-11-09 | 588677087 | 26013128 | 5 | adar1-avoro-deeptrack-ecor1-orbimed |
| 16 | QURE | 2025-09-30 | uniQure N.V. | 44,295,995.00 | 2014-02-05 | 585353213 | 10028323 | 8 | adar1-avoro-deeptrack-ecor1-logos-perceptive-racapital-orbimed |
| 17 | MRUS | 2025-09-30 | Merus N.V. | 55,639,246.00 | 2016-05-19 | 574624095 | 6103283 | 5 | adar1-avoro-baker-perceptive-tang |
| 18 | CDTX | 2025-09-30 | Cidara Therapeutics, Inc. | 3,569,414.00 | 2015-04-15 | 546165436 | 5703482 | 6 | adar1-baker-bvf-deeptrack-logos-racapital |
| 19 | ACLX | 2025-09-30 | Arcellx, Inc. | 32,601,579.00 | 2022-02-04 | 545405817 | 6643189 | 6 | adar1-baker-cormorant-logos-perceptive-racapital |
| 20 | GPCR | 2025-09-30 | Structure Therapeutics Inc. | 148,959,516.00 | 2023-02-03 | 537832680 | 19208310 | 9 | adar1-avoro-baker-bvf-casdin-deeptrack-logos-racapital-orbimed |
| 21 | AKRO | 2025-09-30 | Akero Therapeutics, Inc. | 66,438,220.00 | 2019-06-20 | 529367434 | 11149272 | 7 | adar1-avoro-baker-deeptrack-logos-perceptive-orbimed |
| 22 | KRYS | 2025-09-30 | Krystal Biotech, Inc. | 22,823,920.00 | 2017-09-20 | 517946964 | 2934045 | 4 | adar1-avoro-perceptive-orbimed |
| 23 | ZYME | 2025-09-30 | Zymeworks Inc. | 38,672,223.00 | 2017-04-28 | 515810739 | 30199692 | 5 | bvf-ecor1-perceptive-opaleye-tang |
| 24 | ABVX | 2025-09-30 | Abivax SA | 30,875,904.00 | 2023-10-20 | 502460358 | 5918261 | 7 | adar1-baker-bvf-cormorant-logos-perceptive-orbimed |
| 25 | PTGX | 2025-09-30 | Protagonist Therapeutics, Inc. | 46,016,118.00 | 2016-08-11 | 445142315 | 6700923 | 6 | adar1-bvf-deeptrack-logos-perceptive-opaleye |
| 26 | ARWR | 2025-09-30 | Arrowhead Pharmaceuticals, Inc. | 108,000,510.00 | 1993-12-16 | 435283183 | 12620562 | 3 | adar1-avoro-baker |
| 27 | CNTA | 2025-09-30 | Centessa Pharmaceuticals plc | 93,006,626.00 | 2021-05-28 | 416194215 | 17162648 | 7 | adar1-avoro-cormorant-ecor1-logos-perceptive-tang |
| 28 | JANX | 2025-09-30 | Janux Therapeutics, Inc. | 37,290,619.00 | 2021-06-11 | 393105449 | 16084511 | 7 | adar1-cormorant-logos-perceptive-racapital-orbimed-tang |
| 29 | TARS | 2025-09-30 | Tarsus Pharmaceuticals, Inc. | 29,909,637.00 | 2020-10-16 | 353768783 | 5952697 | 4 | cormorant-deeptrack-orbimed-tang |
| 30 | NAMS | 2025-09-30 | NewAmsterdam Pharma Company N.V | 53,941,411.00 | 2021-02-09 | 353460767 | 12428297 | 3 | adar1-cormorant-racapital |
| 31 | MLYS | 2025-09-30 | Mineralys Therapeutics, Inc. | 33,142,194.00 | 2023-02-10 | 343990597 | 9071482 | 4 | adar1-racapital-orbimed-tang |
| 32 | WGS | 2025-09-30 | GeneDx Holdings Corp. | 18,444,224.00 | 2020-11-04 | 341019510 | 3165208 | 3 | casdin-racapital-tang |
| 33 | ALKS | 2025-09-30 | Alkermes plc | 160,028,503.00 | 1991-07-16 | 340126530 | 11337551 | 5 | adar1-avoro-baker-ecor1-opaleye |
| 34 | IONS | 2025-09-30 | Ionis Pharmaceuticals, Inc. | 157,589,727.00 | 1991-05-17 | 330944079 | 5058760 | 4 | adar1-baker-deeptrack-tang |
| 35 | IMCR | 2025-09-30 | Immunocore Holdings plc | 37,260,699.00 | 2021-02-05 | 321613214 | 8852552 | 5 | baker-bvf-deeptrack-logos-tang |
| 36 | OCUL | 2025-09-30 | Ocular Therapeutix, Inc. | 124,121,633.00 | 2014-07-25 | 315947232 | 27027137 | 4 | avoro-deeptrack-logos-opaleye |
| 37 | XENE | 2025-09-30 | Xenon Pharmaceuticals Inc. | 70,775,310.00 | 2014-11-05 | 312354835 | 7779697 | 6 | adar1-avoro-baker-deeptrack-perceptive-orbimed |
| 38 | IMVT | 2025-09-30 | Immunovant, Inc. | 62,221,667.00 | 2019-06-21 | 310976868 | 19291369 | 5 | adar1-baker-deeptrack-logos-perceptive |
| 39 | KOD | 2025-09-30 | Kodiak Sciences Inc | 32,340,149.00 | 2018-10-04 | 295397746 | 18045067 | 3 | baker-perceptive-tang |
New Positions (Not previously in any of the funds) Sorted by Value
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | Position | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | VOR | 2025-09-30 | Vor Biopharma Inc. | 38,992,387.00 | 2021-02-05 | 99013705 | 2032301 | 2 | racapital-tang | New |
| 1 | BLTE | 2025-09-30 | Belite Bio, Inc | 14,281,527.00 | 2022-04-29 | 68434312 | 924788 | 2 | perceptive-racapital | New |
| 2 | DHR | 2025-09-30 | Danaher Corporation | 634,598,025.00 | 1978-12-29 | 52162206 | 263100 | 1 | orbimed | New |
| 3 | CI | 2025-09-30 | The Cigna Group | 272,359,334.00 | 1982-03-31 | 46927100 | 162800 | 1 | orbimed | New |
| 4 | PGEN | 2025-09-30 | Precigen, Inc. | 147,094,997.00 | 2013-08-08 | 40796000 | 12400000 | 1 | tang | New |
| 5 | TEM | 2025-09-30 | Tempus AI, Inc. | 98,524,608.00 | 2024-06-14 | 30599340 | 379127 | 2 | casdin-perceptive | New |
| 6 | ASMB | 2025-09-30 | Assembly Biosciences, Inc. | 4,501,431.00 | 2010-12-17 | 26607539 | 1039357 | 2 | adar1-racapital | New |
| 7 | IRTC | 2025-09-30 | iRhythm Technologies, Inc. | 31,001,606.00 | 2016-10-20 | 21154770 | 123000 | 1 | perceptive | New |
| 8 | IMA | 2025-09-30 | 75244 | NaN | 2021-03-26 09:30:00 | 16782267 | 2059174 | 3 | bvf-deeptrack-orbimed | New |
| 9 | CARL | 2025-09-30 | Carlsmed, Inc. | NaN | 2025-07-23 09:30:00 | 16772314 | 1252600 | 1 | orbimed | New |
| 10 | XFOR | 2025-09-30 | X4 Pharmaceuticals, Inc. | 131,920,887.00 | 2017-11-16 | 11478293 | 3356226 | 2 | bvf-deeptrack | New |
| 11 | INSP | 2025-09-30 | Inspire Medical Systems, Inc. | 29,200,037.00 | 2018-05-03 | 8970854 | 120901 | 2 | adar1-racapital | New |
| 12 | EQ | 2025-09-30 | Equillium, Inc. | 18,182,775.00 | 2018-10-12 | 7950783 | 5559988 | 1 | adar1 | New |
| 13 | BTSG | 2025-09-30 | BrightSpring Health Services, I | 69,664,071.00 | 2024-01-26 | 7797928 | 263800 | 1 | orbimed | New |
| 14 | COGT | 2025-09-30 | Cogent Biosciences, Inc. | 69,993,334.00 | 2018-03-29 | 7180000 | 500000 | 1 | logos | New |
| 15 | ATAI | 2025-09-30 | ATAI Life Sciences N.V. | 154,550,136.00 | 2021-06-18 | 6666680 | 1260242 | 2 | adar1-orbimed | New |
| 16 | IMRX | 2025-09-30 | Immuneering Corporation | 27,234,477.00 | 2021-07-30 | 6650000 | 950000 | 1 | logos | New |
| 17 | MIST | 2025-09-30 | Milestone Pharmaceuticals Inc. | 53,004,370.00 | 2019-05-09 | 6443656 | 3221828 | 1 | orbimed | New |
| 18 | SLGL | 2025-09-30 | Sol-Gel Technologies Ltd. | 8,240,005.00 | 2018-02-01 | 5970940 | 204835 | 1 | opaleye | New |
| 19 | PLX | 2025-09-30 | Protalix BioTherapeutics, Inc. | 59,149,480.00 | 1998-05-15 | 5728834 | 2580556 | 1 | opaleye | New |
| 20 | EPRX | 2025-09-30 | Eupraxia Pharmaceuticals Inc. | 24,915,659.00 | 2024-04-05 | 5310000 | 900000 | 1 | logos | New |
| 21 | HTFL | 2025-09-30 | Heartflow, Inc. | 79,410,281.00 | 2025-08-08 09:30:00 | 5049000 | 150000 | 1 | perceptive | New |
| 22 | EVH | 2025-09-30 | Evolent Health, Inc | 113,203,505.00 | 2015-06-05 | 4898780 | 579052 | 1 | racapital | New |
| 23 | TMCI | 2025-09-30 | Treace Medical Concepts, Inc. | 47,365,889.00 | 2021-04-23 | 4712064 | 702245 | 1 | opaleye | New |
| 24 | GKOS | 2025-09-30 | Glaukos Corporation | 54,680,371.00 | 2015-06-25 | 4418379 | 54180 | 1 | racapital | New |
| 25 | ATHA | 2025-09-30 | Athira Pharma, Inc. | 27,560,062.00 | 2020-09-18 | 2485217 | 600294 | 2 | perceptive-tang | New |
| 26 | MASI | 2025-09-30 | Masimo Corporation | 45,031,596.00 | 2007-08-08 | 2213250 | 15000 | 1 | adar1 | New |
| 27 | PGNY | 2025-09-30 | Progyny, Inc. | 71,965,816.00 | 2019-10-25 | 2079435 | 96628 | 1 | racapital | New |
| 28 | ESPR | 2025-09-30 | Esperion Therapeutics, Inc. | 195,662,656.00 | 2013-06-26 | 1987500 | 750000 | 1 | logos | New |
| 29 | CGTX | 2025-09-30 | Cognition Therapeutics, Inc. | 55,626,916.00 | 2021-10-08 | 1620000 | 1200000 | 1 | tang | New |
| 30 | GBIO | 2025-09-30 | Generation Bio Co. | 48,781,725.00 | 2020-06-12 | 1325818 | 216637 | 2 | adar1-baker | New |
| 31 | PASG | 2025-09-30 | Passage Bio, Inc. | 48,820,577.00 | 2020-02-28 | 1076389 | 134046 | 2 | orbimed-tang | New |
| 32 | RIGL | 2025-09-30 | Rigel Pharmaceuticals, Inc. | 15,340,708.00 | 2000-11-29 | 1070506 | 37787 | 1 | opaleye | New |
| 33 | MREO | 2025-09-30 | Mereo BioPharma Group plc | 486,079,784.00 | 2019-04-24 | 1030000 | 500000 | 1 | logos | New |
| 34 | BDSX | 2025-09-30 | Biodesix, Inc. | 66,204,129.00 | 2020-10-28 | 820639 | 108694 | 1 | perceptive | New |
| 35 | GUTS | 2025-09-30 | Fractyl Health, Inc. | 18,121,028.00 | 2024-02-02 | 815824 | 513097 | 2 | adar1-logos | New |
| 36 | SUPN | 2025-09-30 | Supernus Pharmaceuticals, Inc. | 48,489,960.00 | 2012-05-01 | 689036 | 14418 | 1 | adar1 | New |
| 37 | NVCR | 2025-09-30 | NovoCure Limited | 94,501,988.00 | 2015-10-01 | 439280 | 34000 | 1 | adar1 | New |
| 38 | INBS | 2025-09-30 | Intelligent Bio Solutions Inc. | 5,197,640.00 | 2020-12-23 | 434962 | 426433 | 1 | adar1 | New |
| 39 | KPTI | 2025-09-30 | Karyopharm Therapeutics Inc. | 7,241,049.00 | 2013-11-06 | 163500 | 25000 | 1 | adar1 | New |
------------------------------------------------------------ ------------------------------------------------------------ New Positions (Not previously in any of the funds) Sorted by Number of Funds initiating the new position
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|
| 0 | IMA | 2025-09-30 | 75244 | NaN | 2021-03-26 09:30:00 | 16782267 | 2059174 | 3 | bvf-deeptrack-orbimed |
| 1 | VOR | 2025-09-30 | Vor Biopharma Inc. | 38,992,387.00 | 2021-02-05 | 99013705 | 2032301 | 2 | racapital-tang |
| 2 | BLTE | 2025-09-30 | Belite Bio, Inc | 14,281,527.00 | 2022-04-29 | 68434312 | 924788 | 2 | perceptive-racapital |
| 3 | GBIO | 2025-09-30 | Generation Bio Co. | 48,781,725.00 | 2020-06-12 | 1325818 | 216637 | 2 | adar1-baker |
| 4 | ATAI | 2025-09-30 | ATAI Life Sciences N.V. | 154,550,136.00 | 2021-06-18 | 6666680 | 1260242 | 2 | adar1-orbimed |
| 5 | PASG | 2025-09-30 | Passage Bio, Inc. | 48,820,577.00 | 2020-02-28 | 1076389 | 134046 | 2 | orbimed-tang |
| 6 | XFOR | 2025-09-30 | X4 Pharmaceuticals, Inc. | 131,920,887.00 | 2017-11-16 | 11478293 | 3356226 | 2 | bvf-deeptrack |
| 7 | INSP | 2025-09-30 | Inspire Medical Systems, Inc. | 29,200,037.00 | 2018-05-03 | 8970854 | 120901 | 2 | adar1-racapital |
| 8 | GUTS | 2025-09-30 | Fractyl Health, Inc. | 18,121,028.00 | 2024-02-02 | 815824 | 513097 | 2 | adar1-logos |
| 9 | ASMB | 2025-09-30 | Assembly Biosciences, Inc. | 4,501,431.00 | 2010-12-17 | 26607539 | 1039357 | 2 | adar1-racapital |
| 10 | TEM | 2025-09-30 | Tempus AI, Inc. | 98,524,608.00 | 2024-06-14 | 30599340 | 379127 | 2 | casdin-perceptive |
| 11 | ATHA | 2025-09-30 | Athira Pharma, Inc. | 27,560,062.00 | 2020-09-18 | 2485217 | 600294 | 2 | perceptive-tang |
| 12 | BDSX | 2025-09-30 | Biodesix, Inc. | 66,204,129.00 | 2020-10-28 | 820639 | 108694 | 1 | perceptive |
| 13 | GKOS | 2025-09-30 | Glaukos Corporation | 54,680,371.00 | 2015-06-25 | 4418379 | 54180 | 1 | racapital |
| 14 | MREO | 2025-09-30 | Mereo BioPharma Group plc | 486,079,784.00 | 2019-04-24 | 1030000 | 500000 | 1 | logos |
| 15 | RIGL | 2025-09-30 | Rigel Pharmaceuticals, Inc. | 15,340,708.00 | 2000-11-29 | 1070506 | 37787 | 1 | opaleye |
| 16 | SUPN | 2025-09-30 | Supernus Pharmaceuticals, Inc. | 48,489,960.00 | 2012-05-01 | 689036 | 14418 | 1 | adar1 |
| 17 | NVCR | 2025-09-30 | NovoCure Limited | 94,501,988.00 | 2015-10-01 | 439280 | 34000 | 1 | adar1 |
| 18 | CGTX | 2025-09-30 | Cognition Therapeutics, Inc. | 55,626,916.00 | 2021-10-08 | 1620000 | 1200000 | 1 | tang |
| 19 | ESPR | 2025-09-30 | Esperion Therapeutics, Inc. | 195,662,656.00 | 2013-06-26 | 1987500 | 750000 | 1 | logos |
| 20 | PGNY | 2025-09-30 | Progyny, Inc. | 71,965,816.00 | 2019-10-25 | 2079435 | 96628 | 1 | racapital |
| 21 | INBS | 2025-09-30 | Intelligent Bio Solutions Inc. | 5,197,640.00 | 2020-12-23 | 434962 | 426433 | 1 | adar1 |
| 22 | MASI | 2025-09-30 | Masimo Corporation | 45,031,596.00 | 2007-08-08 | 2213250 | 15000 | 1 | adar1 |
| 23 | EPRX | 2025-09-30 | Eupraxia Pharmaceuticals Inc. | 24,915,659.00 | 2024-04-05 | 5310000 | 900000 | 1 | logos |
| 24 | TMCI | 2025-09-30 | Treace Medical Concepts, Inc. | 47,365,889.00 | 2021-04-23 | 4712064 | 702245 | 1 | opaleye |
| 25 | EVH | 2025-09-30 | Evolent Health, Inc | 113,203,505.00 | 2015-06-05 | 4898780 | 579052 | 1 | racapital |
| 26 | HTFL | 2025-09-30 | Heartflow, Inc. | 79,410,281.00 | 2025-08-08 09:30:00 | 5049000 | 150000 | 1 | perceptive |
| 27 | PLX | 2025-09-30 | Protalix BioTherapeutics, Inc. | 59,149,480.00 | 1998-05-15 | 5728834 | 2580556 | 1 | opaleye |
| 28 | SLGL | 2025-09-30 | Sol-Gel Technologies Ltd. | 8,240,005.00 | 2018-02-01 | 5970940 | 204835 | 1 | opaleye |
| 29 | MIST | 2025-09-30 | Milestone Pharmaceuticals Inc. | 53,004,370.00 | 2019-05-09 | 6443656 | 3221828 | 1 | orbimed |
| 30 | IMRX | 2025-09-30 | Immuneering Corporation | 27,234,477.00 | 2021-07-30 | 6650000 | 950000 | 1 | logos |
| 31 | COGT | 2025-09-30 | Cogent Biosciences, Inc. | 69,993,334.00 | 2018-03-29 | 7180000 | 500000 | 1 | logos |
| 32 | BTSG | 2025-09-30 | BrightSpring Health Services, I | 69,664,071.00 | 2024-01-26 | 7797928 | 263800 | 1 | orbimed |
| 33 | EQ | 2025-09-30 | Equillium, Inc. | 18,182,775.00 | 2018-10-12 | 7950783 | 5559988 | 1 | adar1 |
| 34 | CARL | 2025-09-30 | Carlsmed, Inc. | NaN | 2025-07-23 09:30:00 | 16772314 | 1252600 | 1 | orbimed |
| 35 | IRTC | 2025-09-30 | iRhythm Technologies, Inc. | 31,001,606.00 | 2016-10-20 | 21154770 | 123000 | 1 | perceptive |
| 36 | PGEN | 2025-09-30 | Precigen, Inc. | 147,094,997.00 | 2013-08-08 | 40796000 | 12400000 | 1 | tang |
| 37 | CI | 2025-09-30 | The Cigna Group | 272,359,334.00 | 1982-03-31 | 46927100 | 162800 | 1 | orbimed |
| 38 | DHR | 2025-09-30 | Danaher Corporation | 634,598,025.00 | 1978-12-29 | 52162206 | 263100 | 1 | orbimed |
| 39 | KPTI | 2025-09-30 | Karyopharm Therapeutics Inc. | 7,241,049.00 | 2013-11-06 | 163500 | 25000 | 1 | adar1 |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ASND | 2025-09-30 | Ascendis Pharma A/S | 59,372,631.00 | 2015-01-28 | 3321766586 | 16708247 | 5 | adar1-avoro-perceptive-racapital-orbimed | 2.75% | Increased |
| 1 | INCY | 2025-09-30 | Incyte Corporation | 161,370,279.00 | 1993-11-04 | 2615851059 | 30843663 | 2 | baker-casdin | 0.33% | Increased |
| 2 | MDGL | 2025-09-30 | Madrigal Pharmaceuticals, Inc. | 11,356,312.00 | 2007-02-06 | 1859681002 | 4054596 | 4 | adar1-avoro-baker-ecor1 | 1.95% | Increased |
| 3 | RYTM | 2025-09-30 | Rhythm Pharmaceuticals, Inc. | 46,955,630.00 | 2017-10-09 | 1521707219 | 431317234 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye | 2878.08% | Increased |
| 4 | RNA | 2025-09-30 | Avidity Biosciences, Inc. | 92,698,110.00 | 2020-06-12 | 960656326 | 22048573 | 9 | adar1-avoro-baker-casdin-cormorant-ecor1-logos-racapital-orbimed | 12.76% | Increased |
| 5 | ACAD | 2025-09-30 | ACADIA Pharmaceuticals Inc. | 114,380,229.00 | 2004-05-27 | 949667879 | 44501775 | 3 | baker-deeptrack-tang | 0.24% | Increased |
| 6 | SMMT | 2025-09-30 | Summit Therapeutics Inc. | 111,183,085.00 | 2015-03-05 | 710206983 | 34375943 | 3 | adar1-baker-tang | 1.15% | Increased |
| 7 | CELC | 2025-09-30 | Celcuity Inc. | 20,768,907.00 | 2017-09-20 | 630568869 | 12764552 | 5 | baker-bvf-perceptive-orbimed-tang | 20.99% | Increased |
| 8 | PCVX | 2025-09-30 | Vaxcyte, Inc. | 119,134,116.00 | 2020-06-12 | 609456239 | 16919940 | 7 | adar1-baker-cormorant-deeptrack-logos-racapital-tang | 10.37% | Increased |
| 9 | QURE | 2025-09-30 | uniQure N.V. | 44,295,995.00 | 2014-02-05 | 585353213 | 10028323 | 8 | adar1-avoro-deeptrack-ecor1-logos-perceptive-racapital-orbimed | 31.71% | Increased |
| 10 | CDTX | 2025-09-30 | Cidara Therapeutics, Inc. | 3,569,414.00 | 2015-04-15 | 546165436 | 5703482 | 6 | adar1-baker-bvf-deeptrack-logos-racapital | 17.82% | Increased |
| 11 | ACLX | 2025-09-30 | Arcellx, Inc. | 32,601,579.00 | 2022-02-04 | 545405817 | 6643189 | 6 | adar1-baker-cormorant-logos-perceptive-racapital | 2.28% | Increased |
| 12 | GPCR | 2025-09-30 | Structure Therapeutics Inc. | 148,959,516.00 | 2023-02-03 | 537832680 | 19208310 | 9 | adar1-avoro-baker-bvf-casdin-deeptrack-logos-racapital-orbimed | 35.07% | Increased |
| 13 | AKRO | 2025-09-30 | Akero Therapeutics, Inc. | 66,438,220.00 | 2019-06-20 | 529367434 | 11149272 | 7 | adar1-avoro-baker-deeptrack-logos-perceptive-orbimed | 15.33% | Increased |
| 14 | KRYS | 2025-09-30 | Krystal Biotech, Inc. | 22,823,920.00 | 2017-09-20 | 517946964 | 2934045 | 4 | adar1-avoro-perceptive-orbimed | 5.95% | Increased |
| 15 | ZYME | 2025-09-30 | Zymeworks Inc. | 38,672,223.00 | 2017-04-28 | 515810739 | 30199692 | 5 | bvf-ecor1-perceptive-opaleye-tang | 1.12% | Increased |
| 16 | ARWR | 2025-09-30 | Arrowhead Pharmaceuticals, Inc. | 108,000,510.00 | 1993-12-16 | 435283183 | 12620562 | 3 | adar1-avoro-baker | 8.85% | Increased |
| 17 | CNTA | 2025-09-30 | Centessa Pharmaceuticals plc | 93,006,626.00 | 2021-05-28 | 416194215 | 17162648 | 7 | adar1-avoro-cormorant-ecor1-logos-perceptive-tang | 89.01% | Increased |
| 18 | TARS | 2025-09-30 | Tarsus Pharmaceuticals, Inc. | 29,909,637.00 | 2020-10-16 | 353768783 | 5952697 | 4 | cormorant-deeptrack-orbimed-tang | 26.58% | Increased |
| 19 | NAMS | 2025-09-30 | NewAmsterdam Pharma Company N.V | 53,941,411.00 | 2021-02-09 | 353460767 | 12428297 | 3 | adar1-cormorant-racapital | 0.02% | Increased |
| 20 | MLYS | 2025-09-30 | Mineralys Therapeutics, Inc. | 33,142,194.00 | 2023-02-10 | 343990597 | 9071482 | 4 | adar1-racapital-orbimed-tang | 22.43% | Increased |
| 21 | ALKS | 2025-09-30 | Alkermes plc | 160,028,503.00 | 1991-07-16 | 340126530 | 11337551 | 5 | adar1-avoro-baker-ecor1-opaleye | 15.04% | Increased |
| 22 | IMCR | 2025-09-30 | Immunocore Holdings plc | 37,260,699.00 | 2021-02-05 | 321613214 | 8852552 | 5 | baker-bvf-deeptrack-logos-tang | 13.09% | Increased |
| 23 | OCUL | 2025-09-30 | Ocular Therapeutix, Inc. | 124,121,633.00 | 2014-07-25 | 315947232 | 27027137 | 4 | avoro-deeptrack-logos-opaleye | 6.03% | Increased |
| 24 | IMVT | 2025-09-30 | Immunovant, Inc. | 62,221,667.00 | 2019-06-21 | 310976868 | 19291369 | 5 | adar1-baker-deeptrack-logos-perceptive | 7.74% | Increased |
| 25 | KOD | 2025-09-30 | Kodiak Sciences Inc | 32,340,149.00 | 2018-10-04 | 295397746 | 18045067 | 3 | baker-perceptive-tang | 3.64% | Increased |
| 26 | ANAB | 2025-09-30 | AnaptysBio, Inc. | 18,032,374.00 | 2017-01-26 | 282124504 | 9213733 | 2 | ecor1-tang | 0.03% | Increased |
| 27 | CRNX | 2025-09-30 | Crinetics Pharmaceuticals, Inc. | 91,642,575.00 | 2018-07-18 | 263040075 | 6315488 | 5 | adar1-baker-cormorant-ecor1-orbimed | 2.35% | Increased |
| 28 | NUVL | 2025-09-30 | Nuvalent, Inc. | 40,974,058.00 | 2021-07-29 | 260700100 | 3014571 | 5 | adar1-baker-perceptive-racapital-tang | 90.68% | Increased |
| 29 | ROIV | 2025-09-30 | Roivant Sciences Ltd. | 370,553,369.00 | 2020-12-08 | 260213804 | 17198533 | 4 | adar1-baker-perceptive-orbimed | 45.51% | Increased |
| 30 | VRDN | 2025-09-30 | Viridian Therapeutics, Inc. | 76,929,941.00 | 2014-06-18 | 248858056 | 11531884 | 5 | adar1-baker-deeptrack-perceptive-tang | 8.94% | Increased |
| 31 | LENZ | 2025-09-30 | LENZ Therapeutics, Inc. | 11,210,776.00 | 2021-06-25 | 237001741 | 5088058 | 3 | adar1-racapital-tang | 0.23% | Increased |
| 32 | SPRY | 2025-09-30 | ARS Pharmaceuticals, Inc. | 47,452,700.00 | 2020-12-04 | 209127607 | 20808717 | 4 | adar1-casdin-racapital-orbimed | 2.76% | Increased |
| 33 | KNSA | 2025-09-30 | Kiniksa Pharmaceuticals, Ltd. | 23,218,552.00 | 2018-05-25 | 203021295 | 5228465 | 3 | adar1-baker-tang | 0.36% | Increased |
| 34 | GLPG | 2025-09-30 | Galapagos NV | 44,538,512.00 | 2012-02-27 | 201546362 | 5818313 | 2 | ecor1-tang | 15.74% | Increased |
| 35 | MBX | 2025-09-30 | MBX Biosciences, Inc. | 13,610,404.00 | 2024-09-13 | 193064691 | 11032268 | 6 | baker-cormorant-deeptrack-ecor1-orbimed-opaleye | 27.42% | Increased |
| 36 | IMTX | 2025-09-30 | Immatics N.V. | 61,326,922.00 | 2018-12-12 | 186964167 | 21944151 | 3 | baker-perceptive-orbimed | 8.25% | Increased |
| 37 | SLNO | 2025-09-30 | Soleno Therapeutics, Inc. | 31,320,071.00 | 2014-11-13 | 179343273 | 2653007 | 3 | adar1-avoro-tang | 4.13% | Increased |
| 38 | PRAX | 2025-09-30 | Praxis Precision Medicines, Inc | 16,083,216.00 | 2020-10-16 | 179089226 | 3379042 | 4 | baker-cormorant-logos-perceptive | 2.63% | Increased |
| 39 | STOK | 2025-09-30 | Stoke Therapeutics, Inc. | 37,143,295.00 | 2019-06-19 | 175614349 | 7472951 | 4 | baker-bvf-opaleye-tang | 25.02% | Increased |
| 40 | AMLX | 2025-09-30 | Amylyx Pharmaceuticals, Inc. | 58,959,626.00 | 2022-01-07 | 171494479 | 12619167 | 6 | adar1-cormorant-logos-perceptive-orbimed-tang | 32.55% | Increased |
| 41 | IDYA | 2025-09-30 | IDEAYA Biosciences, Inc. | 86,629,628.00 | 2019-05-23 | 161775531 | 5945444 | 4 | adar1-baker-logos-tang | 8.82% | Increased |
| 42 | RAPP | 2025-09-30 | Rapport Therapeutics, Inc. | 14,741,641.00 | 2024-06-07 | 152762960 | 5143534 | 3 | baker-cormorant-perceptive | 35.42% | Increased |
| 43 | ISRG | 2025-09-30 | Intuitive Surgical, Inc. | 354,513,456.00 | 2000-06-16 | 151753636 | 339319 | 2 | perceptive-orbimed | 0.95% | Increased |
| 44 | BBIO | 2025-09-30 | BridgeBio Pharma, Inc. | 139,058,316.00 | 2019-06-27 | 149245123 | 2873414 | 3 | adar1-cormorant-deeptrack | 4.12% | Increased |
| 45 | EYPT | 2025-09-30 | EyePoint Pharmaceuticals, Inc. | 43,542,419.00 | 2005-01-27 | 144123040 | 10121000 | 2 | cormorant-orbimed | 21.57% | Increased |
| 46 | EXAS | 2025-09-30 | Exact Sciences Corporation | 184,254,502.00 | 2001-02-01 | 142521848 | 2605042 | 5 | casdin-deeptrack-perceptive-racapital-orbimed | 273.58% | Increased |
| 47 | WVE | 2025-09-30 | Wave Life Sciences Ltd. | 70,126,228.00 | 2015-11-11 | 136628817 | 18665139 | 3 | adar1-baker-racapital | 0.02% | Increased |
| 48 | CMPX | 2025-09-30 | Compass Therapeutics, Inc. | 83,586,239.00 | 2021-04-05 | 136086850 | 38881957 | 5 | adar1-bvf-logos-orbimed-tang | 35.28% | Increased |
| 49 | TVTX | 2025-09-30 | Travere Therapeutics, Inc. | 75,506,943.00 | 2012-11-08 | 134906299 | 5644615 | 3 | perceptive-racapital-tang | 110.29% | Increased |
| 50 | TNGX | 2025-09-30 | Tango Therapeutics, Inc. | 46,645,311.00 | 2020-09-03 | 130874503 | 15580298 | 5 | avoro-deeptrack-ecor1-logos-racapital | 23.35% | Increased |
| 51 | CTMX | 2025-09-30 | CytomX Therapeutics, Inc. | 73,975,451.00 | 2015-10-08 | 128126089 | 40164918 | 6 | adar1-baker-perceptive-racapital-orbimed-tang | 12.36% | Increased |
| 52 | AUPH | 2025-09-30 | Aurinia Pharmaceuticals Inc | 133,424,854.00 | 2014-09-03 | 125190975 | 11329500 | 1 | tang | 12.85% | Increased |
| 53 | ORIC | 2025-09-30 | Oric Pharmaceuticals, Inc. | 46,231,360.00 | 2020-04-24 | 124438464 | 10369872 | 2 | ecor1-orbimed | 311.94% | Increased |
| 54 | PEPG | 2025-09-30 | PepGen Inc. | 10,471,699.00 | 2022-05-06 | 118601207 | 25671257 | 8 | adar1-bvf-deeptrack-ecor1-logos-perceptive-racapital-opaleye | 134.44% | Increased |
| 55 | OLMA | 2025-09-30 | Olema Pharmaceuticals, Inc. | 41,105,755.00 | 2020-11-19 | 117589060 | 12011140 | 4 | adar1-bvf-deeptrack-logos | 0.53% | Increased |
| 56 | NRIX | 2025-09-30 | Nurix Therapeutics, Inc. | 59,122,228.00 | 2020-07-24 | 105211242 | 11386498 | 4 | adar1-baker-deeptrack-perceptive | 2.81% | Increased |
| 57 | LAB | 2025-09-30 | Standard BioTools Inc. | 48,240,936.00 | 2011-02-10 | 101356595 | 77966611 | 2 | casdin-tang | 1.94% | Increased |
| 58 | FULC | 2025-09-30 | Fulcrum Therapeutics, Inc. | 26,503,299.00 | 2019-07-18 | 97250541 | 10570711 | 2 | adar1-racapital | 2.80% | Increased |
| 59 | CRSP | 2025-09-30 | CRISPR Therapeutics AG | 85,368,761.00 | 2016-10-19 | 96519978 | 1489276 | 2 | ecor1-tang | 7.20% | Increased |
| 60 | PTCT | 2025-09-30 | PTC Therapeutics, Inc. | 63,207,489.00 | 2013-06-20 | 92055000 | 1500000 | 1 | tang | 36.36% | Increased |
| 61 | DRUG | 2025-09-30 | Bright Minds Biosciences Inc. | 2,524,284.00 | 2021-03-22 | 91512949 | 1508621 | 2 | cormorant-perceptive | 1.93% | Increased |
| 62 | LQDA | 2025-09-30 | Liquidia Corporation | 66,205,312.00 | 2018-07-26 | 85474180 | 3758759 | 2 | opaleye-tang | 3.87% | Increased |
| 63 | FDMT | 2025-09-30 | 4D Molecular Therapeutics, Inc. | 34,309,158.00 | 2020-12-11 | 80028052 | 9209212 | 3 | adar1-bvf-racapital | 0.18% | Increased |
| 64 | NKTR | 2025-09-30 | Nektar Therapeutics | 173,991,966.00 | 1994-05-03 | 76735454 | 1348602 | 2 | adar1-bvf | 8437.62% | Increased |
| 65 | APGE | 2025-09-30 | Apogee Therapeutics, Inc. | 39,041,674.00 | 2023-07-14 | 76092724 | 1915246 | 3 | perceptive-opaleye-tang | 36.78% | Increased |
| 66 | ARVN | 2025-09-30 | Arvinas, Inc. | 53,685,383.00 | 2018-09-27 | 68494060 | 8039209 | 4 | adar1-logos-opaleye-tang | 23.63% | Increased |
| 67 | DNLI | 2025-09-30 | Denali Therapeutics Inc. | 131,342,965.00 | 2017-12-08 | 67855023 | 4673211 | 3 | adar1-baker-casdin | 0.34% | Increased |
| 68 | REPL | 2025-09-30 | Replimune Group, Inc. | 53,003,113.00 | 2018-07-20 | 64627524 | 15424230 | 3 | adar1-baker-tang | 2.11% | Increased |
| 69 | BNTX | 2025-09-30 | BioNTech SE | 92,355,164.00 | 2019-10-10 | 63996786 | 648923 | 3 | adar1-baker-tang | 1.57% | Increased |
| 70 | NGNE | 2025-09-30 | Neurogene Inc. | 5,545,438.00 | 2014-03-07 | 62197838 | 3589027 | 4 | adar1-baker-casdin-ecor1 | 0.03% | Increased |
| 71 | KALV | 2025-09-30 | KalVista Pharmaceuticals, Inc. | 29,072,212.00 | 2015-04-09 | 61530900 | 5051798 | 2 | adar1-tang | 2.02% | Increased |
| 72 | CMPS | 2025-09-30 | COMPASS Pathways Plc – American | 71,549,218.00 | 2020-09-18 | 59161018 | 10324785 | 3 | deeptrack-ecor1-tang | 1.91% | Increased |
| 73 | PEN | 2025-09-30 | Penumbra, Inc. | 37,159,032.00 | 2015-09-18 | 55868966 | 220547 | 1 | perceptive | 572.46% | Increased |
| 74 | TRVI | 2025-09-30 | Trevi Therapeutics, Inc. | 73,666,058.00 | 2019-05-07 | 53970360 | 5898400 | 3 | logos-orbimed-opaleye | 28.83% | Increased |
| 75 | MNPR | 2025-09-30 | Monopar Therapeutics Inc. | 3,503,249.00 | 2019-12-19 | 52367294 | 641206 | 2 | adar1-racapital | 4.74% | Increased |
| 76 | SRRK | 2025-09-30 | Scholar Rock Holding Corporatio | 69,786,242.00 | 2018-05-25 | 50716225 | 1361875 | 3 | adar1-logos-racapital | 15.79% | Increased |
| 77 | VSTM | 2025-09-30 | Verastem, Inc. | 38,014,694.00 | 2012-01-27 | 50572686 | 5727371 | 3 | logos-orbimed-tang | 22.53% | Increased |
| 78 | PHVS | 2025-09-30 | Pharvaris N.V. | 19,413,727.00 | 2021-02-05 | 47961984 | 1922324 | 4 | adar1-baker-cormorant-logos | 29.12% | Increased |
| 79 | NTLA | 2025-09-30 | Intellia Therapeutics, Inc. | 97,913,025.00 | 2016-05-06 | 47435060 | 2746674 | 1 | baker | 2.65% | Increased |
| 80 | CRBP | 2025-09-30 | Corbus Pharmaceuticals Holdings | 7,526,368.00 | 2014-10-27 | 46615339 | 3685007 | 4 | adar1-cormorant-orbimed-tang | 0.28% | Increased |
| 81 | BEAM | 2025-09-30 | Beam Therapeutics Inc. | 73,199,019.00 | 2020-02-06 | 45020850 | 1855000 | 2 | casdin-tang | 12.08% | Increased |
| 82 | INBX | 2025-09-30 | Inhibrx Biosciences, Inc. | 7,712,906.00 | 2024-06-04 | 44717171 | 1327707 | 1 | perceptive | 35.77% | Increased |
| 83 | PRME | 2025-09-30 | Prime Medicine, Inc. | 60,638,823.00 | 2022-10-20 | 42716176 | 7710501 | 3 | casdin-ecor1-racapital | 392.00% | Increased |
| 84 | CBIO | 2025-09-30 | Crescent Biopharma, Inc. | NaN | 2014-01-10 09:30:00 | 42507451 | 3575059 | 5 | bvf-deeptrack-logos-perceptive-tang | 23.32% | Increased |
| 85 | VKTX | 2025-09-30 | Viking Therapeutics, Inc. | 109,861,197.00 | 2015-04-28 | 39882501 | 1517599 | 4 | adar1-baker-perceptive-tang | 85.41% | Increased |
| 86 | CTNM | 2025-09-30 | Contineum Therapeutics, Inc. | 13,299,011.00 | 2024-04-05 | 36901534 | 3140556 | 5 | adar1-baker-casdin-perceptive-racapital | 136.64% | Increased |
| 87 | ERAS | 2025-09-30 | Erasca, Inc. | 201,634,202.00 | 2021-07-16 | 36303355 | 16652915 | 2 | logos-tang | 0.91% | Increased |
| 88 | RGEN | 2025-09-30 | Repligen Corporation | 52,524,167.00 | 1986-04-29 | 36148111 | 270428 | 1 | perceptive | 62.91% | Increased |
| 89 | AQST | 2025-09-30 | Aquestive Therapeutics, Inc. | 94,253,087.00 | 2018-07-25 | 35692703 | 6385099 | 2 | ecor1-perceptive | 191.50% | Increased |
| 90 | URGN | 2025-09-30 | UroGen Pharma Ltd. | 36,992,561.00 | 2017-05-04 | 34393800 | 1724000 | 3 | adar1-orbimed-tang | 15.83% | Increased |
| 91 | ANNX | 2025-09-30 | Annexon, Inc. | 81,750,277.00 | 2020-07-24 | 29280000 | 9600000 | 2 | bvf-opaleye | 2.02% | Increased |
| 92 | IVVD | 2025-09-30 | Invivyd, Inc. | 47,996,574.00 | 2021-08-06 | 27379092 | 24890083 | 3 | adar1-racapital-tang | 176.99% | Increased |
| 93 | ALDX | 2025-09-30 | Aldeyra Therapeutics, Inc. | 47,818,870.00 | 2014-05-02 | 27260463 | 5222311 | 1 | perceptive | 21.41% | Increased |
| 94 | ADCT | 2025-09-30 | ADC Therapeutics SA | 73,042,624.00 | 2020-05-18 | 26359520 | 6589880 | 2 | orbimed-opaleye | 11.55% | Increased |
| 95 | GMAB | 2025-09-30 | Genmab A/S | 62,846,320.00 | 2009-06-01 | 20894459 | 681267 | 2 | deeptrack-tang | 240.63% | Increased |
| 96 | DERM | 2025-09-30 | Journey Medical Corporation | 10,945,727.00 | 2021-11-12 | 20118700 | 2825660 | 2 | opaleye-tang | 44.94% | Increased |
| 97 | GOSS | 2025-09-30 | Gossamer Bio, Inc. | 183,672,034.00 | 2019-02-08 | 19857363 | 7550328 | 4 | adar1-perceptive-opaleye-tang | 100.16% | Increased |
| 98 | IKT | 2025-09-30 | Inhibikase Therapeutics, Inc. | 25,709,535.00 | 2020-12-23 | 17284057 | 10669171 | 2 | adar1-perceptive | 1.09% | Increased |
| 99 | NUVB | 2025-09-30 | Nuvation Bio Inc. | 228,079,888.00 | 2020-08-26 | 15540000 | 4200000 | 1 | tang | 7.69% | Increased |
| 100 | PMVP | 2025-09-30 | PMV Pharmaceuticals, Inc. | 34,407,051.00 | 2020-09-25 | 15206099 | 10861500 | 3 | adar1-orbimed-tang | 65.16% | Increased |
| 101 | STTK | 2025-09-30 | Shattuck Labs, Inc. | 24,176,183.00 | 2020-10-09 | 15071644 | 6306127 | 1 | orbimed | 6025.55% | Increased |
| 102 | REGN | 2025-09-30 | Regeneron Pharmaceuticals, Inc. | 102,996,273.00 | 1991-04-02 | 14450339 | 25700 | 2 | adar1-tang | 92.35% | Increased |
| 103 | CABA | 2025-09-30 | Cabaletta Bio, Inc. | 42,831,744.00 | 2019-10-25 | 13592784 | 5808882 | 2 | cormorant-opaleye | 16.18% | Increased |
| 104 | ABUS | 2025-09-30 | Arbutus Biopharma Corporation | 136,309,001.00 | 2007-07-26 | 13180646 | 2903226 | 1 | adar1 | 2.74% | Increased |
| 105 | OBIO | 2025-09-30 | Orchestra BioMed Holdings, Inc. | 18,386,175.00 | 2020-08-04 | 13125539 | 5292556 | 1 | perceptive | 15.24% | Increased |
| 106 | VTYX | 2025-09-30 | Ventyx Biosciences, Inc. | 54,957,214.00 | 2021-10-21 | 13076710 | 4204730 | 3 | adar1-baker-tang | 28.64% | Increased |
| 107 | VTGN | 2025-09-30 | VistaGen Therapeutics, Inc. | 20,224,817.00 | 2011-06-21 | 11264370 | 3173062 | 2 | adar1-orbimed | 654.12% | Increased |
| 108 | LXEO | 2025-09-30 | Lexeo Therapeutics, Inc. | 21,795,488.00 | 2023-11-03 | 11100672 | 1671788 | 2 | adar1-perceptive | 486.71% | Increased |
| 109 | SABS | 2025-09-30 | SAB Biotherapeutics, Inc. | 6,791,463.00 | 2021-02-09 | 10751886 | 5349197 | 3 | adar1-bvf-racapital | 482.81% | Increased |
| 110 | HRTX | 2025-09-30 | Heron Therapeutics, Inc. | 115,963,945.00 | 1987-08-26 | 9704458 | 7701951 | 2 | baker-tang | 260.67% | Increased |
| 111 | BHC | 2025-09-30 | Bausch Health Companies Inc. | 276,207,976.00 | 1994-03-29 | 8385000 | 1300000 | 1 | tang | 76.43% | Increased |
| 112 | PYXS | 2025-09-30 | Pyxis Oncology, Inc. | 44,339,556.00 | 2021-10-08 | 8165842 | 3678307 | 2 | perceptive-tang | 47.13% | Increased |
| 113 | HRMY | 2025-09-30 | Harmony Biosciences Holdings, I | 44,329,878.00 | 2020-08-19 | 8032224 | 291445 | 2 | adar1-tang | 3.64% | Increased |
| 114 | CRMD | 2025-09-30 | CorMedix Inc. | 60,890,203.00 | 2010-05-13 | 5815000 | 500000 | 1 | deeptrack | 185.71% | Increased |
| 115 | ESTA | 2025-09-30 | Establishment Labs Holdings Inc | 16,562,689.00 | 2018-07-19 | 3717301 | 90688 | 1 | adar1 | 262.75% | Increased |
| 116 | ACRS | 2025-09-30 | Aclaris Therapeutics, Inc. | 66,068,981.00 | 2015-10-06 | 3559996 | 1873682 | 2 | adar1-logos | 1.28% | Increased |
| 117 | VTVT | 2025-09-30 | vTv Therapeutics Inc. | 1,072,776.00 | 2015-07-30 | 3463132 | 148314 | 1 | baker | 52.41% | Increased |
| 118 | FENC | 2025-09-30 | Fennec Pharmaceuticals Inc. | 14,403,520.00 | 2017-09-15 | 3131790 | 334593 | 1 | tang | 1530.01% | Increased |
| 119 | IFRX | 2025-09-30 | InflaRx N.V. | 50,522,550.00 | 2017-11-07 | 2857834 | 2132712 | 2 | adar1-racapital | 8.08% | Increased |
| 120 | PFE | 2025-09-30 | Pfizer, Inc. | 5,657,705,935.00 | 1972-06-01 | 2482758 | 97439 | 2 | adar1-tang | 5.41% | Increased |
| 121 | STRO | 2025-09-30 | Sutro Biopharma, Inc. | 70,805,238.00 | 2018-09-27 | 2456458 | 2828717 | 1 | tang | 10.43% | Increased |
| 122 | DCTH | 2025-09-30 | Delcath Systems, Inc. | 31,032,851.00 | 2018-05-03 | 2412139 | 224385 | 1 | adar1 | 50.21% | Increased |
| 123 | OABI | 2025-09-30 | OmniAb, Inc. | 99,520,435.00 | 2021-09-30 | 2225005 | 1390628 | 2 | adar1-tang | 122.11% | Increased |
| 124 | UNCY | 2025-09-30 | Unicycive Therapeutics, Inc. | 70,600,827.00 | 2021-07-12 | 2064735 | 473563 | 1 | logos | 0.00% | Increased |
| 125 | ANRO | 2025-09-30 | Alto Neuroscience, Inc. | 19,503,574.00 | 2024-02-02 | 1629571 | 405366 | 2 | perceptive-orbimed | 62.15% | Increased |
| 126 | BMRN | 2025-09-30 | BioMarin Pharmaceutical Inc. | 178,517,719.00 | 1999-07-26 | 1611585 | 29756 | 2 | adar1-deeptrack | 507.27% | Increased |
| 127 | NVNO | 2025-09-30 | enVVeno Medical Corporation | 17,374,493.00 | 2018-05-31 | 1593686 | 1759035 | 1 | perceptive | 36.89% | Increased |
| 128 | MRK | 2025-09-30 | Merck & Company, Inc. | 2,522,019,842.00 | 1962-01-02 | 1556062 | 18540 | 1 | adar1 | 163.35% | Increased |
| 129 | QNCX | 2025-09-30 | Quince Therapeutics, Inc. | 32,660,220.00 | 2019-05-09 | 1263305 | 775034 | 1 | adar1 | 442.14% | Increased |
| 130 | PACB | 2025-09-30 | Pacific Biosciences of Californ | 295,618,336.00 | 2010-10-27 | 958422 | 748767 | 2 | casdin-tang | 3.45% | Increased |
| 131 | ATYR | 2025-09-30 | aTyr Pharma, Inc. | 81,953,409.00 | 2015-05-07 | 610401 | 846134 | 2 | adar1-tang | 26.08% | Increased |
| 132 | KPRX | 2025-09-30 | Kiora Pharmaceuticals, Inc. | 1,762,573.00 | 2015-02-13 | 466876 | 167941 | 1 | adar1 | 0.50% | Increased |
| 133 | LUNG | 2025-09-30 | Pulmonx Corporation | 38,129,348.00 | 2020-10-01 | 347485 | 214497 | 1 | adar1 | 4.89% | Increased |
| 134 | ACHV | 2025-09-30 | Achieve Life Sciences, Inc. | 29,417,797.00 | 1995-10-12 | 150570 | 47800 | 1 | adar1 | 10.72% | Increased |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by Increase in Share %
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | NKTR | 2025-09-30 | Nektar Therapeutics | 173,991,966.00 | 1994-05-03 | 76735454 | 1348602 | 2 | adar1-bvf | 8437.62% |
| 1 | STTK | 2025-09-30 | Shattuck Labs, Inc. | 24,176,183.00 | 2020-10-09 | 15071644 | 6306127 | 1 | orbimed | 6025.55% |
| 2 | RYTM | 2025-09-30 | Rhythm Pharmaceuticals, Inc. | 46,955,630.00 | 2017-10-09 | 1521707219 | 431317234 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye | 2878.08% |
| 3 | FENC | 2025-09-30 | Fennec Pharmaceuticals Inc. | 14,403,520.00 | 2017-09-15 | 3131790 | 334593 | 1 | tang | 1530.01% |
| 4 | VTGN | 2025-09-30 | VistaGen Therapeutics, Inc. | 20,224,817.00 | 2011-06-21 | 11264370 | 3173062 | 2 | adar1-orbimed | 654.12% |
| 5 | PEN | 2025-09-30 | Penumbra, Inc. | 37,159,032.00 | 2015-09-18 | 55868966 | 220547 | 1 | perceptive | 572.46% |
| 6 | BMRN | 2025-09-30 | BioMarin Pharmaceutical Inc. | 178,517,719.00 | 1999-07-26 | 1611585 | 29756 | 2 | adar1-deeptrack | 507.27% |
| 7 | LXEO | 2025-09-30 | Lexeo Therapeutics, Inc. | 21,795,488.00 | 2023-11-03 | 11100672 | 1671788 | 2 | adar1-perceptive | 486.71% |
| 8 | SABS | 2025-09-30 | SAB Biotherapeutics, Inc. | 6,791,463.00 | 2021-02-09 | 10751886 | 5349197 | 3 | adar1-bvf-racapital | 482.81% |
| 9 | QNCX | 2025-09-30 | Quince Therapeutics, Inc. | 32,660,220.00 | 2019-05-09 | 1263305 | 775034 | 1 | adar1 | 442.14% |
| 10 | PRME | 2025-09-30 | Prime Medicine, Inc. | 60,638,823.00 | 2022-10-20 | 42716176 | 7710501 | 3 | casdin-ecor1-racapital | 392.00% |
| 11 | ORIC | 2025-09-30 | Oric Pharmaceuticals, Inc. | 46,231,360.00 | 2020-04-24 | 124438464 | 10369872 | 2 | ecor1-orbimed | 311.94% |
| 12 | EXAS | 2025-09-30 | Exact Sciences Corporation | 184,254,502.00 | 2001-02-01 | 142521848 | 2605042 | 5 | casdin-deeptrack-perceptive-racapital-orbimed | 273.58% |
| 13 | ESTA | 2025-09-30 | Establishment Labs Holdings Inc | 16,562,689.00 | 2018-07-19 | 3717301 | 90688 | 1 | adar1 | 262.75% |
| 14 | HRTX | 2025-09-30 | Heron Therapeutics, Inc. | 115,963,945.00 | 1987-08-26 | 9704458 | 7701951 | 2 | baker-tang | 260.67% |
| 15 | GMAB | 2025-09-30 | Genmab A/S | 62,846,320.00 | 2009-06-01 | 20894459 | 681267 | 2 | deeptrack-tang | 240.63% |
| 16 | AQST | 2025-09-30 | Aquestive Therapeutics, Inc. | 94,253,087.00 | 2018-07-25 | 35692703 | 6385099 | 2 | ecor1-perceptive | 191.50% |
| 17 | CRMD | 2025-09-30 | CorMedix Inc. | 60,890,203.00 | 2010-05-13 | 5815000 | 500000 | 1 | deeptrack | 185.71% |
| 18 | IVVD | 2025-09-30 | Invivyd, Inc. | 47,996,574.00 | 2021-08-06 | 27379092 | 24890083 | 3 | adar1-racapital-tang | 176.99% |
| 19 | MRK | 2025-09-30 | Merck & Company, Inc. | 2,522,019,842.00 | 1962-01-02 | 1556062 | 18540 | 1 | adar1 | 163.35% |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by the Highest Fund Number
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | RNA | 2025-09-30 | Avidity Biosciences, Inc. | 92,698,110.00 | 2020-06-12 | 960656326 | 22048573 | 9 | adar1-avoro-baker-casdin-cormorant-ecor1-logos-racapital-orbimed | 12.76% |
| 1 | GPCR | 2025-09-30 | Structure Therapeutics Inc. | 148,959,516.00 | 2023-02-03 | 537832680 | 19208310 | 9 | adar1-avoro-baker-bvf-casdin-deeptrack-logos-racapital-orbimed | 35.07% |
| 2 | PEPG | 2025-09-30 | PepGen Inc. | 10,471,699.00 | 2022-05-06 | 118601207 | 25671257 | 8 | adar1-bvf-deeptrack-ecor1-logos-perceptive-racapital-opaleye | 134.44% |
| 3 | QURE | 2025-09-30 | uniQure N.V. | 44,295,995.00 | 2014-02-05 | 585353213 | 10028323 | 8 | adar1-avoro-deeptrack-ecor1-logos-perceptive-racapital-orbimed | 31.71% |
| 4 | CNTA | 2025-09-30 | Centessa Pharmaceuticals plc | 93,006,626.00 | 2021-05-28 | 416194215 | 17162648 | 7 | adar1-avoro-cormorant-ecor1-logos-perceptive-tang | 89.01% |
| 5 | RYTM | 2025-09-30 | Rhythm Pharmaceuticals, Inc. | 46,955,630.00 | 2017-10-09 | 1521707219 | 431317234 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye | 2878.08% |
| 6 | AKRO | 2025-09-30 | Akero Therapeutics, Inc. | 66,438,220.00 | 2019-06-20 | 529367434 | 11149272 | 7 | adar1-avoro-baker-deeptrack-logos-perceptive-orbimed | 15.33% |
| 7 | PCVX | 2025-09-30 | Vaxcyte, Inc. | 119,134,116.00 | 2020-06-12 | 609456239 | 16919940 | 7 | adar1-baker-cormorant-deeptrack-logos-racapital-tang | 10.37% |
| 8 | MBX | 2025-09-30 | MBX Biosciences, Inc. | 13,610,404.00 | 2024-09-13 | 193064691 | 11032268 | 6 | baker-cormorant-deeptrack-ecor1-orbimed-opaleye | 27.42% |
| 9 | ACLX | 2025-09-30 | Arcellx, Inc. | 32,601,579.00 | 2022-02-04 | 545405817 | 6643189 | 6 | adar1-baker-cormorant-logos-perceptive-racapital | 2.28% |
| 10 | CTMX | 2025-09-30 | CytomX Therapeutics, Inc. | 73,975,451.00 | 2015-10-08 | 128126089 | 40164918 | 6 | adar1-baker-perceptive-racapital-orbimed-tang | 12.36% |
| 11 | CDTX | 2025-09-30 | Cidara Therapeutics, Inc. | 3,569,414.00 | 2015-04-15 | 546165436 | 5703482 | 6 | adar1-baker-bvf-deeptrack-logos-racapital | 17.82% |
| 12 | AMLX | 2025-09-30 | Amylyx Pharmaceuticals, Inc. | 58,959,626.00 | 2022-01-07 | 171494479 | 12619167 | 6 | adar1-cormorant-logos-perceptive-orbimed-tang | 32.55% |
| 13 | IMCR | 2025-09-30 | Immunocore Holdings plc | 37,260,699.00 | 2021-02-05 | 321613214 | 8852552 | 5 | baker-bvf-deeptrack-logos-tang | 13.09% |
| 14 | VRDN | 2025-09-30 | Viridian Therapeutics, Inc. | 76,929,941.00 | 2014-06-18 | 248858056 | 11531884 | 5 | adar1-baker-deeptrack-perceptive-tang | 8.94% |
| 15 | NUVL | 2025-09-30 | Nuvalent, Inc. | 40,974,058.00 | 2021-07-29 | 260700100 | 3014571 | 5 | adar1-baker-perceptive-racapital-tang | 90.68% |
| 16 | CTNM | 2025-09-30 | Contineum Therapeutics, Inc. | 13,299,011.00 | 2024-04-05 | 36901534 | 3140556 | 5 | adar1-baker-casdin-perceptive-racapital | 136.64% |
| 17 | CBIO | 2025-09-30 | Crescent Biopharma, Inc. | NaN | 2014-01-10 09:30:00 | 42507451 | 3575059 | 5 | bvf-deeptrack-logos-perceptive-tang | 23.32% |
| 18 | CRNX | 2025-09-30 | Crinetics Pharmaceuticals, Inc. | 91,642,575.00 | 2018-07-18 | 263040075 | 6315488 | 5 | adar1-baker-cormorant-ecor1-orbimed | 2.35% |
| 19 | IMVT | 2025-09-30 | Immunovant, Inc. | 62,221,667.00 | 2019-06-21 | 310976868 | 19291369 | 5 | adar1-baker-deeptrack-logos-perceptive | 7.74% |
------------------------------------------------------------ ------------------------------------------------------------ Closed Positions (No longer in any in any of the funds) Sorted by Value
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | Position | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | THC | 2025-06-30 | Tenet Healthcare Corporation | 93,879,671.00 | 1980-03-17 | 81840000 | 465000 | 1 | orbimed | Closed |
| 1 | RXST | 2025-06-30 | RxSight, Inc. | 32,215,490.00 | 2021-07-30 | 48138571 | 3702967 | 1 | racapital | Closed |
| 2 | PODD | 2025-06-30 | Insulet Corporation | 69,910,789.00 | 2007-05-15 | 18972388 | 60387 | 1 | perceptive | Closed |
| 3 | HNGE | 2025-06-30 | Hinge Health, Inc. | 4,695,728.00 | 2025-05-22 09:30:00 | 15525000 | 300000 | 1 | racapital | Closed |
| 4 | CRL | 2025-06-30 | Charles River Laboratories Inte | 50,549,899.00 | 2000-06-23 | 15173000 | 100000 | 1 | perceptive | Closed |
| 5 | ELAN | 2025-06-30 | Elanco Animal Health Incorporat | 490,780,682.00 | 2018-09-20 | 11425428 | 800100 | 1 | tang | Closed |
| 6 | PCRX | 2025-06-30 | Pacira BioSciences, Inc. | 43,487,172.00 | 2011-02-03 | 10933557 | 457471 | 1 | ecor1 | Closed |
| 7 | NVAX | 2025-06-30 | Novavax, Inc. | 135,577,182.00 | 1995-12-05 | 10070815 | 1598542 | 2 | deeptrack-tang | Closed |
| 8 | CPRX | 2025-06-30 | Catalyst Pharmaceuticals, Inc. | 113,799,541.00 | 2006-11-08 | 9046730 | 416900 | 1 | orbimed | Closed |
| 9 | ANIK | 2025-06-30 | Anika Therapeutics Inc. | 10,199,202.00 | 1993-05-03 | 6229472 | 588797 | 1 | opaleye | Closed |
| 10 | TXG | 2025-06-30 | 10x Genomics, Inc. | 106,469,868.00 | 2019-09-12 | 5504472 | 475343 | 1 | racapital | Closed |
| 11 | GMED | 2025-06-30 | Globus Medical, Inc. | 114,224,212.00 | 2012-08-03 | 5223270 | 88500 | 1 | perceptive | Closed |
| 12 | INO | 2025-06-30 | Inovio Pharmaceuticals, Inc. | 33,103,900.00 | 1998-12-08 | 4032088 | 1981370 | 1 | deeptrack | Closed |
| 13 | ARDX | 2025-06-30 | Ardelyx, Inc. | 231,291,344.00 | 2014-06-19 | 3587310 | 915130 | 1 | adar1 | Closed |
| 14 | ALEC | 2025-06-30 | Alector, Inc. | 73,332,475.00 | 2019-02-07 | 2412936 | 1723526 | 1 | adar1 | Closed |
| 15 | RCEL | 2025-06-30 | Avita Medical, Inc. | 25,848,578.00 | 2012-05-14 | 2060556 | 389519 | 1 | opaleye | Closed |
| 16 | ACHC | 2025-06-30 | Acadia Healthcare Company, Inc. | 90,430,406.00 | 1994-03-04 | 2025355 | 89262 | 1 | racapital | Closed |
| 17 | CADL | 2025-06-30 | Candel Therapeutics, Inc. | 35,925,874.00 | 2021-07-27 | 1796867 | 355112 | 1 | baker | Closed |
| 18 | ALXO | 2025-06-30 | ALX Oncology Holdings Inc. | 32,339,047.00 | 2020-07-17 | 1310996 | 3158265 | 1 | tang | Closed |
| 19 | TPST | 2025-06-30 | Tempest Therapeutics, Inc. | 3,222,289.00 | 2012-11-12 | 944942 | 138962 | 1 | tang | Closed |
| 20 | APLT | 2025-06-30 | Applied Therapeutics, Inc. | 103,058,488.00 | 2019-05-14 | 755403 | 2428169 | 1 | tang | Closed |
| 21 | PYPD | 2025-06-30 | PolyPid Ltd. | 4,590,187.00 | 2020-06-26 | 366944 | 103950 | 1 | adar1 | Closed |
| 22 | MCRB | 2025-06-30 | Seres Therapeutics, Inc. | 128,451,837.00 | 2015-06-26 | 154662 | 13921 | 1 | tang | Closed |
| 23 | AVXL | 2025-06-30 | Anavex Life Sciences Corp. | 82,257,080.00 | 2006-08-02 | 149558 | 16221 | 1 | adar1 | Closed |
| 24 | RLMD | 2025-06-30 | Relmada Therapeutics, Inc. | 30,568,156.00 | 2014-06-20 | 78039 | 130000 | 1 | adar1 | Closed |
| 25 | CASI | 2025-06-30 | CASI Pharmaceuticals, Inc. | 7,353,446.00 | 1996-06-12 | 52062 | 44120 | 1 | adar1 | Closed |
| 26 | ACTU | 2025-06-30 | Actuate Therapeutics, Inc. | 5,962,227.00 | 2024-08-13 | 32035 | 5243 | 1 | tang | Closed |
| 27 | GALT | 2025-06-30 | Galectin Therapeutics Inc. | 44,013,425.00 | 2002-09-04 | 27246 | 12913 | 1 | tang | Closed |
| 28 | RNXT | 2025-06-30 | RenovoRx, Inc. | 35,057,106.00 | 2021-08-26 | 26154 | 19889 | 1 | adar1 | Closed |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | INSM | 2025-09-30 | Insmed Incorporated | 166,410,802.00 | 2000-06-01 | 1159147003 | 8049073 | 5 | baker-cormorant-perceptive-orbimed-tang | -25.93% | Decreased |
| 1 | KYMR | 2025-09-30 | Kymera Therapeutics, Inc. | 42,816,370.00 | 2020-08-21 | 1071094721 | 18923935 | 5 | avoro-baker-bvf-logos-perceptive | -0.05% | Decreased |
| 2 | UTHR | 2025-09-30 | United Therapeutics Corporation | 41,324,592.00 | 1999-06-17 | 900598066 | 2148322 | 3 | adar1-avoro-orbimed | -12.49% | Decreased |
| 3 | ARGX | 2025-09-30 | argenx SE | 60,989,637.00 | 2017-05-18 | 885116254 | 1200060 | 3 | avoro-baker-orbimed | -15.64% | Decreased |
| 4 | RVMD | 2025-09-30 | Revolution Medicines, Inc. | 168,212,518.00 | 2020-02-13 | 848386711 | 18166739 | 7 | adar1-baker-bvf-casdin-logos-opaleye-tang | -5.75% | Decreased |
| 5 | EWTX | 2025-09-30 | Edgewise Therapeutics, Inc. | 54,187,991.00 | 2021-03-26 | 681727622 | 42030063 | 8 | adar1-baker-cormorant-perceptive-racapital-orbimed-opaleye-tang | -1.29% | Decreased |
| 6 | APLS | 2025-09-30 | Apellis Pharmaceuticals, Inc. | 84,226,131.00 | 2017-11-09 | 588677087 | 26013128 | 5 | adar1-avoro-deeptrack-ecor1-orbimed | -20.25% | Decreased |
| 7 | MRUS | 2025-09-30 | Merus N.V. | 55,639,246.00 | 2016-05-19 | 574624095 | 6103283 | 5 | adar1-avoro-baker-perceptive-tang | -5.40% | Decreased |
| 8 | ABVX | 2025-09-30 | Abivax SA | 30,875,904.00 | 2023-10-20 | 502460358 | 5918261 | 7 | adar1-baker-bvf-cormorant-logos-perceptive-orbimed | -31.83% | Decreased |
| 9 | PTGX | 2025-09-30 | Protagonist Therapeutics, Inc. | 46,016,118.00 | 2016-08-11 | 445142315 | 6700923 | 6 | adar1-bvf-deeptrack-logos-perceptive-opaleye | -21.94% | Decreased |
| 10 | JANX | 2025-09-30 | Janux Therapeutics, Inc. | 37,290,619.00 | 2021-06-11 | 393105449 | 16084511 | 7 | adar1-cormorant-logos-perceptive-racapital-orbimed-tang | -4.96% | Decreased |
| 11 | WGS | 2025-09-30 | GeneDx Holdings Corp. | 18,444,224.00 | 2020-11-04 | 341019510 | 3165208 | 3 | casdin-racapital-tang | -13.64% | Decreased |
| 12 | IONS | 2025-09-30 | Ionis Pharmaceuticals, Inc. | 157,589,727.00 | 1991-05-17 | 330944079 | 5058760 | 4 | adar1-baker-deeptrack-tang | -28.78% | Decreased |
| 13 | XENE | 2025-09-30 | Xenon Pharmaceuticals Inc. | 70,775,310.00 | 2014-11-05 | 312354835 | 7779697 | 6 | adar1-avoro-baker-deeptrack-perceptive-orbimed | -8.78% | Decreased |
| 14 | GHRS | 2025-09-30 | GH Research PLC | 17,280,108.00 | 2021-06-25 | 281636756 | 19694878 | 5 | bvf-cormorant-deeptrack-racapital-tang | -3.99% | Decreased |
| 15 | JAZZ | 2025-09-30 | Jazz Pharmaceuticals plc | 58,903,824.00 | 2007-06-01 | 276644114 | 2098969 | 4 | adar1-ecor1-logos-tang | -10.65% | Decreased |
| 16 | SEPN | 2025-09-30 | Septerna, Inc. | 19,629,806.00 | 2024-10-25 | 276580454 | 14703905 | 7 | adar1-avoro-bvf-casdin-logos-perceptive-racapital | -0.67% | Decreased |
| 17 | CYTK | 2025-09-30 | Cytokinetics, Incorporated | 117,836,397.00 | 2004-04-30 | 270343898 | 4918921 | 3 | adar1-deeptrack-tang | -9.06% | Decreased |
| 18 | BSX | 2025-09-30 | Boston Scientific Corporation | 1,471,454,074.00 | 1992-05-19 | 267437859 | 2739300 | 2 | perceptive-orbimed | -11.44% | Decreased |
| 19 | GH | 2025-09-30 | Guardant Health, Inc. | 111,589,027.00 | 2018-10-04 | 266170173 | 4260086 | 3 | adar1-casdin-deeptrack | -2.07% | Decreased |
| 20 | AXSM | 2025-09-30 | Axsome Therapeutics, Inc. | 36,674,021.00 | 2015-11-19 | 263237653 | 2167457 | 5 | bvf-cormorant-deeptrack-perceptive-orbimed | -32.65% | Decreased |
| 21 | IRON | 2025-09-30 | Disc Medicine, Inc. | 26,301,510.00 | 2020-08-12 | 262532470 | 3972949 | 5 | baker-logos-racapital-orbimed-opaleye | -5.76% | Decreased |
| 22 | LLY | 2025-09-30 | Eli Lilly and Company | 895,933,556.00 | 1972-06-01 | 238208600 | 312200 | 3 | adar1-orbimed-tang | -12.45% | Decreased |
| 23 | TYRA | 2025-09-30 | Tyra Biosciences, Inc. | 21,075,120.00 | 2021-09-15 | 221867774 | 15859026 | 3 | baker-bvf-racapital | -6.48% | Decreased |
| 24 | VERA | 2025-09-30 | Vera Therapeutics, Inc. | 50,541,557.00 | 2021-05-14 | 219693600 | 7560000 | 2 | avoro-tang | -1.18% | Decreased |
| 25 | MIRM | 2025-09-30 | Mirum Pharmaceuticals, Inc. | 38,862,861.00 | 2019-07-18 | 200232849 | 2731317 | 2 | bvf-tang | -31.67% | Decreased |
| 26 | FOLD | 2025-09-30 | Amicus Therapeutics, Inc. | 250,897,044.00 | 2007-05-31 | 181565058 | 23041251 | 3 | avoro-perceptive-orbimed | -16.81% | Decreased |
| 27 | DVAX | 2025-09-30 | Dynavax Technologies Corporatio | 99,188,424.00 | 2004-02-19 | 177209281 | 17845849 | 3 | adar1-deeptrack-tang | -10.37% | Decreased |
| 28 | ELVN | 2025-09-30 | Enliven Therapeutics, Inc. | 26,934,302.00 | 2020-03-12 | 176336175 | 8614371 | 4 | baker-cormorant-logos-orbimed | -9.07% | Decreased |
| 29 | TSHA | 2025-09-30 | Taysha Gene Therapies, Inc. | 127,701,667.00 | 2020-09-24 | 173297195 | 52996084 | 5 | adar1-avoro-baker-racapital-tang | -0.33% | Decreased |
| 30 | MLTX | 2025-09-30 | MoonLake Immunotherapeutics | 28,073,483.00 | 2020-10-20 | 171341145 | 23896952 | 4 | adar1-avoro-bvf-cormorant | -26.76% | Decreased |
| 31 | BLFS | 2025-09-30 | BioLife Solutions, Inc. | 36,395,390.00 | 1989-11-22 | 171099779 | 6707165 | 1 | casdin | -12.97% | Decreased |
| 32 | ALNY | 2025-09-30 | Alnylam Pharmaceuticals, Inc. | 124,460,110.00 | 2004-06-01 | 162609600 | 356600 | 2 | casdin-orbimed | -15.78% | Decreased |
| 33 | DNTH | 2025-09-30 | Dianthus Therapeutics, Inc. | 14,121,907.00 | 2018-06-21 | 162168592 | 4121184 | 4 | baker-logos-racapital-tang | -33.04% | Decreased |
| 34 | ABCL | 2025-09-30 | AbCellera Biologics Inc. | 202,801,468.00 | 2020-12-11 | 151531969 | 30125640 | 2 | baker-tang | -9.99% | Decreased |
| 35 | BCAX | 2025-09-30 | Bicara Therapeutics Inc. | 28,372,303.00 | 2024-09-13 | 148368445 | 9396355 | 3 | adar1-deeptrack-racapital | -4.17% | Decreased |
| 36 | GERN | 2025-09-30 | Geron Corporation | 601,237,820.00 | 1996-07-31 | 139646927 | 101932064 | 3 | adar1-deeptrack-racapital | -1.82% | Decreased |
| 37 | KROS | 2025-09-30 | Keros Therapeutics, Inc. | 30,728,590.00 | 2020-04-08 | 137269855 | 8676982 | 4 | adar1-logos-orbimed-tang | -11.70% | Decreased |
| 38 | NBIX | 2025-09-30 | Neurocrine Biosciences, Inc. | 98,515,061.00 | 1996-05-23 | 133879002 | 953690 | 3 | perceptive-orbimed-tang | -4.02% | Decreased |
| 39 | EW | 2025-09-30 | Edwards Lifesciences Corporatio | 581,838,751.00 | 2000-03-27 | 130964680 | 1684000 | 1 | orbimed | -1.41% | Decreased |
| 40 | XNCR | 2025-09-30 | Xencor, Inc. | 63,604,579.00 | 2013-12-03 | 125104179 | 10665318 | 5 | adar1-baker-bvf-deeptrack-ecor1 | -6.78% | Decreased |
| 41 | CGON | 2025-09-30 | CG Oncology, Inc. | 60,853,824.00 | 2024-01-25 | 124798195 | 3098267 | 5 | adar1-cormorant-orbimed-opaleye-tang | -8.32% | Decreased |
| 42 | TERN | 2025-09-30 | Terns Pharmaceuticals, Inc. | 53,712,485.00 | 2021-02-05 | 113160462 | 15067971 | 3 | adar1-deeptrack-orbimed | -0.12% | Decreased |
| 43 | SLDB | 2025-09-30 | Solid Biosciences Inc. | 39,269,557.00 | 2018-01-26 | 108869416 | 17644962 | 2 | perceptive-racapital | -0.41% | Decreased |
| 44 | RLAY | 2025-09-30 | Relay Therapeutics, Inc. | 119,707,854.00 | 2020-07-16 | 107373083 | 20569556 | 3 | baker-casdin-tang | -0.28% | Decreased |
| 45 | UPB | 2025-09-30 | Upstream Bio, Inc. | 31,148,731.00 | 2024-10-11 | 107096409 | 5693589 | 1 | orbimed | -20.22% | Decreased |
| 46 | SYRE | 2025-09-30 | Spyre Therapeutics, Inc. | 46,620,133.00 | 2016-04-07 | 92657593 | 5528496 | 5 | adar1-baker-perceptive-opaleye-tang | -1.44% | Decreased |
| 47 | DYN | 2025-09-30 | Dyne Therapeutics, Inc. | 97,275,317.00 | 2020-09-17 | 92247482 | 7292291 | 5 | adar1-deeptrack-logos-perceptive-orbimed | -51.11% | Decreased |
| 48 | AORT | 2025-09-30 | Artivion, Inc. | 36,399,595.00 | 1993-02-12 | 85526800 | 2020000 | 1 | perceptive | -27.69% | Decreased |
| 49 | KURA | 2025-09-30 | Kura Oncology, Inc. | 59,769,977.00 | 2015-09-16 | 85355259 | 9644662 | 4 | adar1-bvf-ecor1-tang | -20.22% | Decreased |
| 50 | IMNM | 2025-09-30 | Immunome, Inc. | 69,554,437.00 | 2020-10-02 | 85066300 | 7264415 | 2 | ecor1-opaleye | -4.53% | Decreased |
| 51 | BCYC | 2025-09-30 | Bicycle Therapeutics plc | NaN | 2019-05-23 | 84252663 | 10885357 | 1 | baker | -9.95% | Decreased |
| 52 | RARE | 2025-09-30 | Ultragenyx Pharmaceutical Inc. | 89,184,961.00 | 2014-01-31 | 83673295 | 2781692 | 2 | adar1-baker | -41.10% | Decreased |
| 53 | GLUE | 2025-09-30 | Monte Rosa Therapeutics, Inc. | 33,917,745.00 | 2021-06-24 | 80605928 | 10877993 | 4 | adar1-baker-bvf-casdin | -24.39% | Decreased |
| 54 | CLDX | 2025-09-30 | Celldex Therapeutics, Inc. | 57,785,116.00 | 1986-05-15 | 71784387 | 2774812 | 3 | adar1-baker-deeptrack | -16.49% | Decreased |
| 55 | ANIP | 2025-09-30 | ANI Pharmaceuticals, Inc. | 16,794,626.00 | 2000-05-05 | 70303000 | 767500 | 2 | deeptrack-tang | -24.57% | Decreased |
| 56 | NTRA | 2025-09-30 | Natera, Inc. | 130,699,355.00 | 2015-07-01 | 69104421 | 429300 | 1 | orbimed | -27.96% | Decreased |
| 57 | RAPT | 2025-09-30 | RAPT Therapeutics, Inc. | 58,439,423.00 | 2019-10-31 | 65240988 | 2529701 | 4 | adar1-deeptrack-perceptive-orbimed | -43.97% | Decreased |
| 58 | DSGN | 2025-09-30 | Design Therapeutics, Inc. | 25,381,999.00 | 2021-03-29 | 57412906 | 7624556 | 4 | baker-logos-racapital-tang | -1.67% | Decreased |
| 59 | ATXS | 2025-09-30 | Astria Therapeutics, Inc. | 33,969,449.00 | 2015-06-25 | 52993697 | 7279354 | 4 | adar1-logos-perceptive-tang | -3.39% | Decreased |
| 60 | OMDA | 2025-09-30 | Omada Health, Inc. | 5,438,394.00 | 2025-06-06 09:30:00 | 52982856 | 2396330 | 1 | perceptive | -15.21% | Decreased |
| 61 | ILMN | 2025-09-30 | Illumina, Inc. | 157,885,200.00 | 2000-07-28 | 49859250 | 525000 | 1 | casdin | -18.60% | Decreased |
| 62 | AVTX | 2025-09-30 | Avalo Therapeutics, Inc. | 3,682,884.00 | 2015-10-14 | 46825979 | 3684184 | 6 | adar1-bvf-deeptrack-perceptive-racapital-orbimed | -1.48% | Decreased |
| 63 | ENGN | 2025-09-30 | enGene Holdings Inc. | 24,461,582.00 | 2022-02-01 | 45489057 | 6660184 | 3 | cormorant-deeptrack-perceptive | -12.22% | Decreased |
| 64 | BIOA | 2025-09-30 | BioAge Labs, Inc. | 23,819,840.00 | 2024-09-26 | 37700084 | 6411579 | 4 | adar1-cormorant-orbimed-tang | -2.85% | Decreased |
| 65 | VRTX | 2025-09-30 | Vertex Pharmaceuticals Incorpor | 256,181,277.00 | 1991-07-24 | 34072680 | 87000 | 2 | adar1-tang | -60.51% | Decreased |
| 66 | EOLS | 2025-09-30 | Evolus, Inc. Common Stock | 56,934,307.00 | 2018-02-08 | 33698156 | 5488299 | 1 | tang | -26.55% | Decreased |
| 67 | ADMA | 2025-09-30 | ADMA Biologics Inc | 232,872,303.00 | 2013-10-17 | 32302841 | 2203468 | 2 | perceptive-tang | -6.37% | Decreased |
| 68 | CDXS | 2025-09-30 | Codexis, Inc. | 63,397,051.00 | 2010-04-22 | 31219800 | 12795000 | 1 | opaleye | -35.38% | Decreased |
| 69 | LRMR | 2025-09-30 | Larimar Therapeutics, Inc. | 31,346,135.00 | 2014-06-19 | 30852659 | 10001907 | 3 | adar1-racapital-opaleye | -3.76% | Decreased |
| 70 | ALMS | 2025-09-30 | Alumis Inc. | 4,764,450.00 | 2024-06-28 | 30043180 | 7529619 | 6 | adar1-baker-cormorant-orbimed-opaleye-tang | -10.85% | Decreased |
| 71 | ITGR | 2025-09-30 | Integer Holdings Corporation | 32,987,365.00 | 2000-09-29 | 29965700 | 290000 | 1 | orbimed | -33.09% | Decreased |
| 72 | SRPT | 2025-09-30 | Sarepta Therapeutics, Inc. | 92,551,132.00 | 1997-06-04 | 29575731 | 1534807 | 3 | adar1-opaleye-tang | -35.53% | Decreased |
| 73 | ZLAB | 2025-09-30 | Zai Lab Limited | 983,033,752.00 | 2017-09-20 | 29442954 | 868780 | 1 | adar1 | -19.66% | Decreased |
| 74 | MNMD | 2025-09-30 | Mind Medicine (MindMed) Inc. | 70,224,468.00 | 2016-11-15 | 29098003 | 2468024 | 3 | deeptrack-orbimed-tang | -20.39% | Decreased |
| 75 | LEGN | 2025-09-30 | Legend Biotech Corporation | 161,989,576.00 | 2020-06-05 | 27066300 | 830000 | 1 | tang | -23.15% | Decreased |
| 76 | ABOS | 2025-09-30 | Acumen Pharmaceuticals, Inc. | 32,793,241.00 | 2021-07-01 | 27057751 | 15823246 | 2 | adar1-racapital | -0.16% | Decreased |
| 77 | KRRO | 2025-09-30 | Korro Bio, Inc. | 4,913,494.00 | 2019-10-03 | 25747340 | 537635 | 3 | adar1-cormorant-orbimed | -36.31% | Decreased |
| 78 | ELDN | 2025-09-30 | Eledon Pharmaceuticals, Inc. | 46,043,696.00 | 2014-09-17 | 25536415 | 9859620 | 2 | bvf-racapital | -0.17% | Decreased |
| 79 | MNKD | 2025-09-30 | MannKind Corporation | 298,491,009.00 | 2004-07-28 | 23997869 | 4468877 | 1 | avoro | -23.61% | Decreased |
| 80 | BCRX | 2025-09-30 | BioCryst Pharmaceuticals, Inc. | 195,072,537.00 | 1994-03-04 | 22401885 | 2951500 | 3 | avoro-orbimed-tang | -44.31% | Decreased |
| 81 | BIIB | 2025-09-30 | Biogen Inc. | 146,001,681.00 | 1991-09-17 | 21432240 | 153000 | 3 | adar1-logos-tang | -36.28% | Decreased |
| 82 | FBRX | 2025-09-30 | Forte Biosciences, Inc. | 3,572,266.00 | 2017-04-13 | 18934575 | 1262305 | 2 | bvf-orbimed | -31.90% | Decreased |
| 83 | CYBN | 2025-09-30 | Cybin Inc. | 18,315,557.00 | 2019-09-13 | 16865278 | 2863375 | 3 | adar1-deeptrack-tang | -14.78% | Decreased |
| 84 | VIR | 2025-09-30 | Vir Biotechnology, Inc. | 92,043,716.00 | 2019-10-11 | 16691781 | 2923254 | 2 | baker-orbimed | -7.88% | Decreased |
| 85 | RZLT | 2025-09-30 | Rezolute, Inc. | 52,813,526.00 | 2013-01-14 | 16162520 | 1719417 | 2 | adar1-opaleye | -9.16% | Decreased |
| 86 | CERS | 2025-09-30 | Cerus Corporation | 158,448,986.00 | 1997-01-31 | 15913269 | 10008345 | 1 | baker | -22.32% | Decreased |
| 87 | ARQT | 2025-09-30 | Arcutis Biotherapeutics, Inc. | 85,242,758.00 | 2020-01-31 | 14608750 | 775000 | 1 | cormorant | -22.50% | Decreased |
| 88 | PRTA | 2025-09-30 | Prothena Corporation plc | 32,018,442.00 | 2012-12-18 | 14338396 | 1469098 | 1 | adar1 | -56.47% | Decreased |
| 89 | AVIR | 2025-09-30 | Atea Pharmaceuticals, Inc. | 66,621,549.00 | 2020-10-30 | 13995980 | 4826200 | 1 | tang | -1.29% | Decreased |
| 90 | CCCC | 2025-09-30 | C4 Therapeutics, Inc. | 47,230,841.00 | 2020-10-02 | 13620024 | 6135146 | 2 | orbimed-tang | -20.64% | Decreased |
| 91 | UNH | 2025-09-30 | UnitedHealth Group Incorporated | 912,224,315.00 | 1984-10-17 | 9572010 | 27721 | 2 | casdin-tang | -91.82% | Decreased |
| 92 | AGIO | 2025-09-30 | Agios Pharmaceuticals, Inc. | 50,708,827.00 | 2013-07-24 | 9106401 | 226866 | 2 | adar1-baker | -74.33% | Decreased |
| 93 | PLRX | 2025-09-30 | Pliant Therapeutics, Inc. | 50,199,674.00 | 2020-06-03 | 8885100 | 6003446 | 1 | tang | -40.15% | Decreased |
| 94 | AVR | 2025-09-30 | Anteris Technologies Global Cor | 27,873,412.00 | 2024-12-13 | 8562353 | 1902745 | 2 | adar1-perceptive | -14.93% | Decreased |
| 95 | SNY | 2025-09-30 | Sanofi | 1,129,611,427.00 | 2002-07-01 | 8222806 | 174212 | 2 | adar1-tang | -17.04% | Decreased |
| 96 | ALT | 2025-09-30 | Altimmune, Inc. | 76,335,168.00 | 2017-05-26 | 8035027 | 2131307 | 1 | tang | -22.50% | Decreased |
| 97 | SVRA | 2025-09-30 | Savara, Inc. | 101,850,947.00 | 2017-04-28 | 7098188 | 1988288 | 1 | adar1 | -44.78% | Decreased |
| 98 | BLCO | 2025-09-30 | Bausch + Lomb Corporation | 41,284,904.00 | 2022-05-06 | 6698118 | 444467 | 1 | tang | -19.19% | Decreased |
| 99 | TEVA | 2025-09-30 | Teva Pharmaceutical Industries | 1,128,838,460.00 | 1982-02-16 | 5409883 | 267816 | 1 | adar1 | -22.57% | Decreased |
| 100 | TECX | 2025-09-30 | Tectonic Therapeutic, Inc. | 9,868,448.00 | 2018-06-21 | 5258864 | 335173 | 3 | adar1-baker-tang | -87.54% | Decreased |
| 101 | ALGS | 2025-09-30 | Aligos Therapeutics, Inc. | 4,373,872.00 | 2020-10-16 | 5166217 | 527165 | 2 | baker-deeptrack | -21.12% | Decreased |
| 102 | RCKT | 2025-09-30 | Rocket Pharmaceuticals, Inc. | 80,783,728.00 | 2015-02-18 | 4648108 | 1425800 | 2 | adar1-tang | -15.02% | Decreased |
| 103 | AUTL | 2025-09-30 | Autolus Therapeutics plc | 138,094,286.00 | 2018-06-22 | 4186839 | 2568613 | 1 | deeptrack | -84.76% | Decreased |
| 104 | KZR | 2025-09-30 | Kezar Life Sciences, Inc. | 4,911,032.00 | 2018-06-21 | 4046901 | 1037667 | 3 | adar1-orbimed-tang | -2.12% | Decreased |
| 105 | ZURA | 2025-09-30 | Zura Bio Limited | 46,618,074.00 | 2023-03-21 | 3945358 | 911168 | 2 | adar1-deeptrack | -66.56% | Decreased |
| 106 | VYGR | 2025-09-30 | Voyager Therapeutics, Inc. | 45,086,359.00 | 2015-11-11 | 3293765 | 705303 | 2 | adar1-ecor1 | -82.36% | Decreased |
| 107 | SNDX | 2025-09-30 | Syndax Pharmaceuticals, Inc. | 76,941,078.00 | 2016-03-02 | 3077000 | 200000 | 1 | tang | -76.74% | Decreased |
| 108 | TENX | 2025-09-30 | Tenax Therapeutics, Inc. | 3,915,154.00 | 1994-04-04 | 2990555 | 392977 | 2 | adar1-bvf | -20.63% | Decreased |
| 109 | ZNTL | 2025-09-30 | Zentalis Pharmaceuticals, Inc. | 45,013,608.00 | 2020-04-03 | 2893991 | 1916550 | 3 | adar1-opaleye-tang | -45.62% | Decreased |
| 110 | BHVN | 2025-09-30 | Biohaven Ltd. | 84,648,084.00 | 2022-09-23 | 2616858 | 174341 | 3 | adar1-cormorant-tang | -80.24% | Decreased |
| 111 | NMRA | 2025-09-30 | Neumora Therapeutics, Inc. | 85,270,564.00 | 2023-09-14 | 2548000 | 1400000 | 1 | tang | -42.50% | Decreased |
| 112 | TARA | 2025-09-30 | Protara Therapeutics, Inc. | 30,107,039.00 | 2014-10-22 | 2488439 | 572055 | 2 | adar1-baker | -77.60% | Decreased |
| 113 | MTD | 2025-09-30 | Mettler-Toledo International, I | 20,572,592.00 | 1997-11-14 | 2417164 | 1969 | 1 | tang | -89.90% | Decreased |
| 114 | FATE | 2025-09-30 | Fate Therapeutics, Inc. | 99,964,480.00 | 2013-10-01 | 2353394 | 1867773 | 1 | tang | -57.09% | Decreased |
| 115 | RGNX | 2025-09-30 | REGENXBIO Inc. | 41,056,108.00 | 2015-09-17 | 1982197 | 205409 | 1 | adar1 | -1.16% | Decreased |
| 116 | KALA | 2025-09-30 | KALA BIO, Inc. | 3,851,888.00 | 2017-07-20 | 1724444 | 1127088 | 2 | adar1-baker | -43.93% | Decreased |
| 117 | LYRA | 2025-09-30 | Lyra Therapeutics, Inc. | 46,626,967.00 | 2020-05-01 | 1497864 | 229382 | 1 | perceptive | -10.10% | Decreased |
| 118 | IOVA | 2025-09-30 | Iovance Biotherapeutics, Inc. | 251,861,761.00 | 2010-10-15 | 1179959 | 543760 | 1 | tang | -69.79% | Decreased |
| 119 | BCAB | 2025-09-30 | BioAtla, Inc. | 42,296,447.00 | 2020-12-16 | 945227 | 1374076 | 1 | tang | -11.04% | Decreased |
| 120 | DNA | 2025-09-30 | Ginkgo Bioworks Holdings, Inc. | 36,712,127.00 | 2021-04-19 | 532068 | 36493 | 1 | casdin | -93.20% | Decreased |
| 121 | PHAT | 2025-09-30 | Phathom Pharmaceuticals, Inc. | 56,653,838.00 | 2019-10-25 | 504933 | 42900 | 1 | adar1 | -32.36% | Decreased |
| 122 | SGRY | 2025-09-30 | Surgery Partners, Inc. | 74,906,623.00 | 2015-09-30 | 432800 | 20000 | 1 | adar1 | -50.00% | Decreased |
| 123 | MGNX | 2025-09-30 | MacroGenics, Inc. | 52,340,363.00 | 2013-10-10 | 367678 | 218856 | 1 | tang | -87.99% | Decreased |
| 124 | BOLT | 2025-09-30 | Bolt Biotherapeutics, Inc. | 27,481,128.00 | 2021-02-05 | 355796 | 66879 | 1 | tang | -62.36% | Decreased |
| 125 | IBIO | 2025-09-30 | iBio, Inc. | 8,599,460.00 | 2008-08-19 | 332776 | 402000 | 2 | adar1-opaleye | -6.47% | Decreased |
| 126 | VYNE | 2025-09-30 | VYNE Therapeutics Inc. | 10,466,058.00 | 2018-01-25 | 285203 | 851353 | 1 | baker | -37.90% | Decreased |
| 127 | SAVA | 2025-09-30 | Cassava Sciences, Inc. | 43,475,174.00 | 2000-07-14 | 256292 | 88073 | 2 | adar1-tang | -63.28% | Decreased |
| 128 | SPRO | 2025-09-30 | Spero Therapeutics, Inc. | 41,896,412.00 | 2017-11-02 | 217213 | 115539 | 1 | adar1 | -19.72% | Decreased |
| 129 | DAWN | 2025-09-30 | Day One Biopharmaceuticals, Inc | 71,972,855.00 | 2021-05-27 | 197562 | 28023 | 1 | adar1 | -96.85% | Decreased |
| 130 | MGX | 2025-09-30 | Metagenomi, Inc. | 23,310,838.00 | 2024-02-09 | 66379 | 28008 | 1 | tang | -86.00% | Decreased |
| 131 | PHGE | 2025-09-30 | BiomX Inc. | 17,770,088.00 | 2019-03-13 | 40769 | 77656 | 1 | adar1 | -74.08% | Decreased |
| 132 | OVID | 2025-09-30 | Ovid Therapeutics Inc. | 50,468,940.00 | 2017-05-05 | 16700 | 12846 | 1 | adar1 | -99.68% | Decreased |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) Sorted by Decrease in Share %
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | OVID | 2025-09-30 | Ovid Therapeutics Inc. | 50,468,940.00 | 2017-05-05 | 16700 | 12846 | 1 | adar1 | -99.68% |
| 1 | DAWN | 2025-09-30 | Day One Biopharmaceuticals, Inc | 71,972,855.00 | 2021-05-27 | 197562 | 28023 | 1 | adar1 | -96.85% |
| 2 | DNA | 2025-09-30 | Ginkgo Bioworks Holdings, Inc. | 36,712,127.00 | 2021-04-19 | 532068 | 36493 | 1 | casdin | -93.20% |
| 3 | UNH | 2025-09-30 | UnitedHealth Group Incorporated | 912,224,315.00 | 1984-10-17 | 9572010 | 27721 | 2 | casdin-tang | -91.82% |
| 4 | MTD | 2025-09-30 | Mettler-Toledo International, I | 20,572,592.00 | 1997-11-14 | 2417164 | 1969 | 1 | tang | -89.90% |
| 5 | MGNX | 2025-09-30 | MacroGenics, Inc. | 52,340,363.00 | 2013-10-10 | 367678 | 218856 | 1 | tang | -87.99% |
| 6 | TECX | 2025-09-30 | Tectonic Therapeutic, Inc. | 9,868,448.00 | 2018-06-21 | 5258864 | 335173 | 3 | adar1-baker-tang | -87.54% |
| 7 | MGX | 2025-09-30 | Metagenomi, Inc. | 23,310,838.00 | 2024-02-09 | 66379 | 28008 | 1 | tang | -86.00% |
| 8 | AUTL | 2025-09-30 | Autolus Therapeutics plc | 138,094,286.00 | 2018-06-22 | 4186839 | 2568613 | 1 | deeptrack | -84.76% |
| 9 | VYGR | 2025-09-30 | Voyager Therapeutics, Inc. | 45,086,359.00 | 2015-11-11 | 3293765 | 705303 | 2 | adar1-ecor1 | -82.36% |
| 10 | BHVN | 2025-09-30 | Biohaven Ltd. | 84,648,084.00 | 2022-09-23 | 2616858 | 174341 | 3 | adar1-cormorant-tang | -80.24% |
| 11 | TARA | 2025-09-30 | Protara Therapeutics, Inc. | 30,107,039.00 | 2014-10-22 | 2488439 | 572055 | 2 | adar1-baker | -77.60% |
| 12 | SNDX | 2025-09-30 | Syndax Pharmaceuticals, Inc. | 76,941,078.00 | 2016-03-02 | 3077000 | 200000 | 1 | tang | -76.74% |
| 13 | AGIO | 2025-09-30 | Agios Pharmaceuticals, Inc. | 50,708,827.00 | 2013-07-24 | 9106401 | 226866 | 2 | adar1-baker | -74.33% |
| 14 | PHGE | 2025-09-30 | BiomX Inc. | 17,770,088.00 | 2019-03-13 | 40769 | 77656 | 1 | adar1 | -74.08% |
| 15 | IOVA | 2025-09-30 | Iovance Biotherapeutics, Inc. | 251,861,761.00 | 2010-10-15 | 1179959 | 543760 | 1 | tang | -69.79% |
| 16 | ZURA | 2025-09-30 | Zura Bio Limited | 46,618,074.00 | 2023-03-21 | 3945358 | 911168 | 2 | adar1-deeptrack | -66.56% |
| 17 | SAVA | 2025-09-30 | Cassava Sciences, Inc. | 43,475,174.00 | 2000-07-14 | 256292 | 88073 | 2 | adar1-tang | -63.28% |
| 18 | BOLT | 2025-09-30 | Bolt Biotherapeutics, Inc. | 27,481,128.00 | 2021-02-05 | 355796 | 66879 | 1 | tang | -62.36% |
| 19 | VRTX | 2025-09-30 | Vertex Pharmaceuticals Incorpor | 256,181,277.00 | 1991-07-24 | 34072680 | 87000 | 2 | adar1-tang | -60.51% |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) with the Highest Fund Number
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | EWTX | 2025-09-30 | Edgewise Therapeutics, Inc. | 54,187,991.00 | 2021-03-26 | 681727622 | 42030063 | 8 | adar1-baker-cormorant-perceptive-racapital-orbimed-opaleye-tang | -1.29% |
| 1 | SEPN | 2025-09-30 | Septerna, Inc. | 19,629,806.00 | 2024-10-25 | 276580454 | 14703905 | 7 | adar1-avoro-bvf-casdin-logos-perceptive-racapital | -0.67% |
| 2 | RVMD | 2025-09-30 | Revolution Medicines, Inc. | 168,212,518.00 | 2020-02-13 | 848386711 | 18166739 | 7 | adar1-baker-bvf-casdin-logos-opaleye-tang | -5.75% |
| 3 | ABVX | 2025-09-30 | Abivax SA | 30,875,904.00 | 2023-10-20 | 502460358 | 5918261 | 7 | adar1-baker-bvf-cormorant-logos-perceptive-orbimed | -31.83% |
| 4 | JANX | 2025-09-30 | Janux Therapeutics, Inc. | 37,290,619.00 | 2021-06-11 | 393105449 | 16084511 | 7 | adar1-cormorant-logos-perceptive-racapital-orbimed-tang | -4.96% |
| 5 | ALMS | 2025-09-30 | Alumis Inc. | 4,764,450.00 | 2024-06-28 | 30043180 | 7529619 | 6 | adar1-baker-cormorant-orbimed-opaleye-tang | -10.85% |
| 6 | PTGX | 2025-09-30 | Protagonist Therapeutics, Inc. | 46,016,118.00 | 2016-08-11 | 445142315 | 6700923 | 6 | adar1-bvf-deeptrack-logos-perceptive-opaleye | -21.94% |
| 7 | AVTX | 2025-09-30 | Avalo Therapeutics, Inc. | 3,682,884.00 | 2015-10-14 | 46825979 | 3684184 | 6 | adar1-bvf-deeptrack-perceptive-racapital-orbimed | -1.48% |
| 8 | XENE | 2025-09-30 | Xenon Pharmaceuticals Inc. | 70,775,310.00 | 2014-11-05 | 312354835 | 7779697 | 6 | adar1-avoro-baker-deeptrack-perceptive-orbimed | -8.78% |
| 9 | INSM | 2025-09-30 | Insmed Incorporated | 166,410,802.00 | 2000-06-01 | 1159147003 | 8049073 | 5 | baker-cormorant-perceptive-orbimed-tang | -25.93% |
| 10 | XNCR | 2025-09-30 | Xencor, Inc. | 63,604,579.00 | 2013-12-03 | 125104179 | 10665318 | 5 | adar1-baker-bvf-deeptrack-ecor1 | -6.78% |
| 11 | CGON | 2025-09-30 | CG Oncology, Inc. | 60,853,824.00 | 2024-01-25 | 124798195 | 3098267 | 5 | adar1-cormorant-orbimed-opaleye-tang | -8.32% |
| 12 | SYRE | 2025-09-30 | Spyre Therapeutics, Inc. | 46,620,133.00 | 2016-04-07 | 92657593 | 5528496 | 5 | adar1-baker-perceptive-opaleye-tang | -1.44% |
| 13 | DYN | 2025-09-30 | Dyne Therapeutics, Inc. | 97,275,317.00 | 2020-09-17 | 92247482 | 7292291 | 5 | adar1-deeptrack-logos-perceptive-orbimed | -51.11% |
| 14 | IRON | 2025-09-30 | Disc Medicine, Inc. | 26,301,510.00 | 2020-08-12 | 262532470 | 3972949 | 5 | baker-logos-racapital-orbimed-opaleye | -5.76% |
| 15 | AXSM | 2025-09-30 | Axsome Therapeutics, Inc. | 36,674,021.00 | 2015-11-19 | 263237653 | 2167457 | 5 | bvf-cormorant-deeptrack-perceptive-orbimed | -32.65% |
| 16 | GHRS | 2025-09-30 | GH Research PLC | 17,280,108.00 | 2021-06-25 | 281636756 | 19694878 | 5 | bvf-cormorant-deeptrack-racapital-tang | -3.99% |
| 17 | TSHA | 2025-09-30 | Taysha Gene Therapies, Inc. | 127,701,667.00 | 2020-09-24 | 173297195 | 52996084 | 5 | adar1-avoro-baker-racapital-tang | -0.33% |
| 18 | MRUS | 2025-09-30 | Merus N.V. | 55,639,246.00 | 2016-05-19 | 574624095 | 6103283 | 5 | adar1-avoro-baker-perceptive-tang | -5.40% |
| 19 | APLS | 2025-09-30 | Apellis Pharmaceuticals, Inc. | 84,226,131.00 | 2017-11-09 | 588677087 | 26013128 | 5 | adar1-avoro-deeptrack-ecor1-orbimed | -20.25% |
------------------------------------------------------------ ------------------------------------------------------------ Unchanged Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|
| 0 | HROW | 2025-09-30 | Harrow, Inc. | 26,130,229.00 | 2007-09-28 | 188142900 | 3905000 | 1 | opaleye |
| 1 | SYK | 2025-09-30 | Stryker Corporation | 343,306,737.00 | 1980-03-17 | 132785464 | 359200 | 1 | orbimed |
| 2 | CAI | 2025-09-30 | None | NaN | 2025-06-18 09:30:00 | 125023885 | 4133021 | 2 | perceptive-orbimed |
| 3 | XOMA | 2025-09-30 | XOMA Royalty Corporation | 8,907,733.00 | 1986-06-06 | 109661331 | 2845390 | 2 | bvf-opaleye |
| 4 | ETON | 2025-09-30 | Eton Pharmaceuticals, Inc. | 20,737,195.00 | 2018-11-13 | 106271521 | 4890544 | 2 | ecor1-opaleye |
| 5 | MGTX | 2025-09-30 | MeiraGTx Holdings plc | 31,284,119.00 | 2018-06-08 | 103792540 | 12626103 | 1 | perceptive |
| 6 | GRAL | 2025-09-30 | GRAIL, Inc. | 22,501,359.00 | 2024-06-12 | 96389291 | 1630125 | 1 | baker |
| 7 | CRVS | 2025-09-30 | Corvus Pharmaceuticals, Inc. | 52,153,182.00 | 2016-03-23 | 63408539 | 8603601 | 2 | perceptive-orbimed |
| 8 | ACIU | 2025-09-30 | AC Immune SA | 39,596,052.00 | 2016-09-23 | 57286840 | 19822436 | 1 | bvf |
| 9 | AVBP | 2025-09-30 | ArriVent BioPharma, Inc. | 15,838,962.00 | 2024-01-26 | 55854202 | 3027328 | 1 | orbimed |
| 10 | CGEM | 2025-09-30 | Cullinan Therapeutics, Inc. | 38,980,660.00 | 2021-01-08 | 52158358 | 8795676 | 3 | bvf-orbimed-tang |
| 11 | SIBN | 2025-09-30 | SI-BONE, Inc. | 37,756,528.00 | 2018-10-17 | 37962571 | 2578979 | 1 | orbimed |
| 12 | NKTX | 2025-09-30 | Nkarta, Inc. | 48,884,788.00 | 2020-07-10 | 36971659 | 17860705 | 2 | racapital-tang |
| 13 | SNWV | 2025-09-30 | SANUWAVE Health, Inc. | 5,600,874.00 | 2025-03-03 | 36730400 | 980000 | 1 | opaleye |
| 14 | AVDL | 2025-09-30 | Avadel Pharmaceuticals plc | 84,810,689.00 | 1996-06-07 | 32028825 | 2097500 | 1 | tang |
| 15 | PRLD | 2025-09-30 | Prelude Therapeutics Incorporat | 16,835,400.00 | 2020-09-25 | 30287636 | 21033080 | 2 | baker-orbimed |
| 16 | TRDA | 2025-09-30 | Entrada Therapeutics, Inc. | 19,019,077.00 | 2021-10-29 | 28221750 | 4865819 | 1 | baker |
| 17 | NPCE | 2025-09-30 | Neuropace, Inc. | 21,126,966.00 | 2021-04-22 | 26952237 | 2614184 | 1 | orbimed |
| 18 | FHTX | 2025-09-30 | Foghorn Therapeutics Inc. | 25,845,788.00 | 2020-10-23 | 25926780 | 5302000 | 1 | bvf |
| 19 | RPTX | 2025-09-30 | Repare Therapeutics Inc. | 22,476,262.00 | 2020-06-19 | 24034715 | 13656088 | 2 | bvf-orbimed |
| 20 | TGTX | 2025-09-30 | TG Therapeutics, Inc. | 134,539,735.00 | 2010-05-03 | 22939375 | 635000 | 2 | opaleye-tang |
| 21 | TMO | 2025-09-30 | Thermo Fisher Scientific Inc | 376,446,298.00 | 1980-03-17 | 22553430 | 46500 | 1 | orbimed |
| 22 | ACET | 2025-09-30 | Adicet Bio, Inc. | 61,366,056.00 | 2018-01-26 | 22046961 | 27211752 | 3 | racapital-orbimed-tang |
| 23 | GSK | 2025-09-30 | GSK plc | 3,947,946,444.00 | 1980-03-28 | 17264000 | 400000 | 1 | tang |
| 24 | SERA | 2025-09-30 | Sera Prognostics, Inc. | 24,854,185.00 | 2021-07-15 | 16824400 | 5498170 | 1 | baker |
| 25 | TCRX | 2025-09-30 | TScan Therapeutics, Inc. | 37,137,033.00 | 2021-07-16 | 15671776 | 8610866 | 3 | baker-bvf-tang |
| 26 | RCUS | 2025-09-30 | Arcus Biosciences, Inc. | 65,841,832.00 | 2018-03-15 | 15454550 | 1136364 | 1 | racapital |
| 27 | ACRV | 2025-09-30 | Acrivon Therapeutics, Inc. | 11,274,619.00 | 2022-11-15 | 15137603 | 8363317 | 2 | baker-racapital |
| 28 | DBVT | 2025-09-30 | DBV Technologies S.A. | 28,773,868.00 | 2014-10-22 | 14614250 | 1461425 | 1 | baker |
| 29 | HOWL | 2025-09-30 | Werewolf Therapeutics, Inc. | 26,381,231.00 | 2021-04-30 | 13162175 | 6681307 | 1 | racapital |
| 30 | OM | 2025-09-30 | Outset Medical, Inc. | 2,773,914.00 | 2020-09-15 | 11766661 | 833333 | 1 | perceptive |
| 31 | VNDA | 2025-09-30 | Vanda Pharmaceuticals Inc. | 51,637,107.00 | 2006-04-12 | 11743002 | 2353307 | 1 | tang |
| 32 | AZN | 2025-09-30 | Astrazeneca PLC | 1,544,514,614.00 | 1993-05-12 | 11508000 | 150000 | 1 | tang |
| 33 | TDOC | 2025-09-30 | Teladoc Health, Inc. | 159,717,484.00 | 2015-06-30 | 10822000 | 1400000 | 1 | tang |
| 34 | NAUT | 2025-09-30 | Nautilus Biotechnology, Inc. | 46,630,782.00 | 2020-08-07 | 10642108 | 12594211 | 1 | perceptive |
| 35 | IDXX | 2025-09-30 | IDEXX Laboratories, Inc. | 80,436,876.00 | 1991-06-21 | 10222240 | 16000 | 1 | tang |
| 36 | VCYT | 2025-09-30 | Veracyte, Inc. | 77,565,181.00 | 2013-10-30 | 9485654 | 276308 | 1 | casdin |
| 37 | CHRS | 2025-09-30 | Coherus BioSciences, Inc. | 114,413,369.00 | 2014-11-06 | 8376674 | 5107728 | 2 | adar1-tang |
| 38 | ATRA | 2025-09-30 | Atara Biotherapeutics, Inc. | 4,197,850.00 | 2014-10-16 | 8213712 | 573183 | 1 | ecor1 |
| 39 | MRNA | 2025-09-30 | Moderna, Inc. | 359,997,079.00 | 2018-12-07 | 7885899 | 305300 | 1 | tang |
| 40 | BDTX | 2025-09-30 | Black Diamond Therapeutics, Inc | 38,983,042.00 | 2020-01-31 | 7846092 | 2070209 | 1 | tang |
| 41 | SRZN | 2025-09-30 | Surrozen, Inc. | 2,128,396.00 | 2021-01-11 | 7764836 | 602626 | 1 | racapital |
| 42 | CNTX | 2025-09-30 | Context Therapeutics Inc. | 40,555,266.00 | 2021-10-20 | 7528011 | 7770449 | 2 | adar1-deeptrack |
| 43 | BMEA | 2025-09-30 | Biomea Fusion, Inc. | 29,397,656.00 | 2021-04-16 | 7213161 | 3570872 | 1 | cormorant |
| 44 | SANA | 2025-09-30 | Sana Biotechnology, Inc. | 134,123,841.00 | 2021-02-04 | 7209869 | 2030949 | 1 | baker |
| 45 | IMUX | 2025-09-30 | Immunic, Inc. | 64,834,702.00 | 2014-04-17 | 6746860 | 7652972 | 1 | bvf |
| 46 | SGMT | 2025-09-30 | Sagimet Biosciences Inc. – Seri | 19,428,281.00 | 2023-07-17 | 6537553 | 952996 | 1 | baker |
| 47 | IBRX | 2025-09-30 | ImmunityBio, Inc. | 204,851,716.00 | 2015-07-28 | 5739999 | 2333333 | 1 | tang |
| 48 | SKYE | 2025-09-30 | Skye Bioscience, Inc. | 15,691,401.00 | 2015-01-06 | 5701007 | 1450638 | 1 | baker |
| 49 | NSPR | 2025-09-30 | InspireMD Inc. | 16,807,131.00 | 2011-04-12 | 5141506 | 2133405 | 1 | orbimed |
| 50 | MOLN | 2025-09-30 | Molecular Partners AG | 14,882,000.00 | 2021-06-16 | 5023221 | 1353968 | 1 | bvf |
| 51 | QTTB | 2025-09-30 | Q32 Bio Inc. | 5,426,353.00 | 2018-03-28 | 4460914 | 2252987 | 1 | orbimed |
| 52 | IVA | 2025-09-30 | Inventiva S.A. – American Depos | 24,956,237.00 | 2020-07-10 | 3972172 | 686040 | 1 | bvf |
| 53 | TBPH | 2025-09-30 | Theravance Biopharma, Inc. | 21,119,514.00 | 2014-05-16 | 3858897 | 264308 | 1 | tang |
| 54 | DTIL | 2025-09-30 | Precision BioSciences, Inc. | 8,756,605.00 | 2019-03-28 | 3608142 | 653649 | 1 | tang |
| 55 | ABSI | 2025-09-30 | Absci Corporation | 100,727,471.00 | 2021-07-22 | 2958710 | 973260 | 1 | casdin |
| 56 | SEER | 2025-09-30 | Seer, Inc. | 41,961,608.00 | 2020-12-04 | 2917398 | 1344423 | 1 | tang |
| 57 | LNTH | 2025-09-30 | Lantheus Holdings, Inc. | 61,829,554.00 | 2015-06-25 | 2564500 | 50000 | 1 | tang |
| 58 | OPRX | 2025-09-30 | OptimizeRx Corporation | 14,276,611.00 | 2007-11-28 | 2050000 | 100000 | 1 | tang |
| 59 | TRIB | 2025-09-30 | Trinity Biotech plc | 181,493,781.00 | 1992-10-21 | 1861600 | 1790000 | 1 | perceptive |
| 60 | JNJ | 2025-09-30 | Johnson & Johnson | 2,403,933,039.00 | 1962-01-02 | 1756213 | 9472 | 1 | tang |
| 61 | ENTA | 2025-09-30 | Enanta Pharmaceuticals, Inc. | 14,292,378.00 | 2013-03-21 | 1516060 | 126655 | 1 | tang |
| 62 | CDNA | 2025-09-30 | CareDx, Inc. | 54,071,844.00 | 2014-07-17 | 1454000 | 100000 | 1 | tang |
| 63 | VTRS | 2025-09-30 | Viatris Inc. | 1,185,535,855.00 | 1980-03-17 | 1270749 | 128359 | 1 | tang |
| 64 | MURA | 2025-09-30 | Mural Oncology plc | 12,903,301.00 | 2023-11-24 | 1243356 | 600655 | 2 | adar1-orbimed |
| 65 | TRAW | 2025-09-30 | Traws Pharma, Inc. | 4,277,814.00 | 2013-07-25 | 1120232 | 605531 | 1 | orbimed |
| 66 | PBYI | 2025-09-30 | Puma Biotechnology Inc | 42,095,259.00 | 2012-04-24 | 1062000 | 200000 | 1 | tang |
| 67 | IPSC | 2025-09-30 | Century Therapeutics, Inc. | 39,812,176.00 | 2021-06-18 | 1059839 | 2128190 | 2 | casdin-tang |
| 68 | RXRX | 2025-09-30 | Recursion Pharmaceuticals, Inc. | 382,695,117.00 | 2021-04-16 | 977576 | 200323 | 2 | adar1-casdin |
| 69 | FTRE | 2025-09-30 | Fortrea Holdings Inc. | 78,282,776.00 | 2023-06-20 | 842000 | 100000 | 1 | tang |
| 70 | LYEL | 2025-09-30 | Lyell Immunopharma, Inc. | 201,520,273.00 | 2021-06-17 | 840046 | 51727 | 1 | orbimed |
| 71 | XERS | 2025-09-30 | Xeris Biopharma Holdings, Inc. | 146,657,227.00 | 2018-06-21 | 654619 | 80420 | 1 | orbimed |
| 72 | TNYA | 2025-09-30 | Tenaya Therapeutics, Inc. | 55,205,093.00 | 2021-07-30 | 586390 | 361969 | 1 | casdin |
| 73 | APYX | 2025-09-30 | Apyx Medical Corporation | 29,121,701.00 | 2019-01-02 | 321000 | 150000 | 1 | perceptive |
| 74 | TXMD | 2025-09-30 | TherapeuticsMD, Inc. | 9,513,315.00 | 2007-05-09 | 224901 | 209210 | 1 | adar1 |
| 75 | ENSC | 2025-09-30 | Ensysce Biosciences, Inc. | 896,490.00 | 2018-03-14 | 205398 | 86666 | 1 | perceptive |
| 76 | CLOV | 2025-09-30 | Clover Health Investments, Corp | 400,755,222.00 | 2020-06-12 | 147798 | 48300 | 1 | adar1 |
| 77 | OGN | 2025-09-30 | Organon & Co. | 256,822,907.00 | 2021-05-14 | 106800 | 10000 | 1 | adar1 |
| 78 | SLN | 2025-09-30 | Silence Therapeutics Plc – Amer | 66,438,057.00 | 2020-09-08 | 96757 | 18643 | 1 | adar1 |
| 79 | NERV | 2025-09-30 | Minerva Neurosciences, Inc | 5,437,023.00 | 2014-07-01 | 26115 | 12406 | 1 | adar1 |
| 80 | PRQR | 2025-09-30 | ProQR Therapeutics N.V. | 64,438,464.00 | 2014-09-18 | 21300 | 10000 | 1 | adar1 |
| 81 | OPT | 2025-09-30 | Opthea Limited | 785,981,303.00 | 2020-10-16 | 0 | 2087320 | 1 | baker |
------------------------------------------------------------ ------------------------------------------------------------ 13F positions: New: ASMB,ATAI,ATHA,BDSX,BLTE,BTSG,CARL,CGTX,CI,COGT,DHR,EPRX,EQ,ESPR,EVH,GBIO,GKOS,GUTS,HTFL,IMA,IMRX,INBS,INSP,IRTC,KPTI,MASI,MIST,MREO,NVCR,PASG,PGEN,PGNY,PLX,RIGL,SLGL,SUPN,TEM,TMCI,VOR,XFOR Increased: ABUS,ACAD,ACHV,ACLX,ACRS,ADCT,AKRO,ALDX,ALKS,AMLX,ANAB,ANNX,ANRO,APGE,AQST,ARVN,ARWR,ASND,ATYR,AUPH,BBIO,BEAM,BHC,BMRN,BNTX,CABA,CBIO,CDTX,CELC,CMPS,CMPX,CNTA,CRBP,CRMD,CRNX,CRSP,CTMX,CTNM,DCTH,DERM,DNLI,DRUG,ERAS,ESTA,EXAS,EYPT,FDMT,FENC,FULC,GLPG,GMAB,GOSS,GPCR,HRMY,HRTX,IDYA,IFRX,IKT,IMCR,IMTX,IMVT,INBX,INCY,ISRG,IVVD,KALV,KNSA,KOD,KPRX,KRYS,LAB,LENZ,LQDA,LUNG,LXEO,MBX,MDGL,MLYS,MNPR,MRK,NAMS,NGNE,NKTR,NRIX,NTLA,NUVB,NUVL,NVNO,OABI,OBIO,OCUL,OLMA,ORIC,PACB,PCVX,PEN,PEPG,PFE,PHVS,PMVP,PRAX,PRME,PTCT,PYXS,QNCX,QURE,RAPP,REGN,REPL,RGEN,RNA,ROIV,RYTM,SABS,SLNO,SMMT,SPRY,SRRK,STOK,STRO,STTK,TARS,TNGX,TRVI,TVTX,UNCY,URGN,VKTX,VRDN,VSTM,VTGN,VTVT,VTYX,WVE,ZYME Closed: ACHC,ACTU,ALEC,ALXO,ANIK,APLT,ARDX,AVXL,CADL,CASI,CPRX,CRL,ELAN,GALT,GMED,HNGE,INO,MCRB,NVAX,PCRX,PODD,PYPD,RCEL,RLMD,RNXT,RXST,THC,TPST,TXG Decreased: ABCL,ABOS,ABVX,ADMA,AGIO,ALGS,ALMS,ALNY,ALT,ANIP,AORT,APLS,ARGX,ARQT,ATXS,AUTL,AVIR,AVR,AVTX,AXSM,BCAB,BCAX,BCRX,BCYC,BHVN,BIIB,BIOA,BLCO,BLFS,BOLT,BSX,CCCC,CDXS,CERS,CGON,CLDX,CYBN,CYTK,DAWN,DNA,DNTH,DSGN,DVAX,DYN,ELDN,ELVN,ENGN,EOLS,EW,EWTX,FATE,FBRX,FOLD,GERN,GH,GHRS,GLUE,IBIO,ILMN,IMNM,INSM,IONS,IOVA,IRON,ITGR,JANX,JAZZ,KALA,KROS,KRRO,KURA,KYMR,KZR,LEGN,LLY,LRMR,LYRA,MGNX,MGX,MIRM,MLTX,MNKD,MNMD,MRUS,MTD,NBIX,NMRA,NTRA,OMDA,OVID,PHAT,PHGE,PLRX,PRTA,PTGX,RAPT,RARE,RCKT,RGNX,RLAY,RVMD,RZLT,SAVA,SEPN,SGRY,SLDB,SNDX,SNY,SPRO,SRPT,SVRA,SYRE,TARA,TECX,TENX,TERN,TEVA,TSHA,TYRA,UNH,UPB,UTHR,VERA,VIR,VRTX,VYGR,VYNE,WGS,XENE,XNCR,ZLAB,ZNTL,ZURA Unchanged: ABSI,ACET,ACIU,ACRV,APYX,ATRA,AVBP,AVDL,AZN,BDTX,BMEA,CAI,CDNA,CGEM,CHRS,CLOV,CNTX,CRVS,DBVT,DTIL,ENSC,ENTA,ETON,FHTX,FTRE,GRAL,GSK,HOWL,HROW,IBRX,IDXX,IMUX,IPSC,IVA,JNJ,LNTH,LYEL,MGTX,MOLN,MRNA,MURA,NAUT,NERV,NKTX,NPCE,NSPR,OGN,OM,OPRX,OPT,PBYI,PRLD,PRQR,QTTB,RCUS,RPTX,RXRX,SANA,SEER,SERA,SGMT,SIBN,SKYE,SLN,SNWV,SRZN,SYK,TBPH,TCRX,TDOC,TGTX,TMO,TNYA,TRAW,TRDA,TRIB,TXMD,VCYT,VNDA,VTRS,XERS,XOMA
End of Report - 2025-11-15 05:22:19
